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ABSTRACT 
 
 
 
THE UNAVOIDABLE THREAT OF AGGREGATION:   
IMPLICATIONS ON FOLDING AND FUNCTION OF A β-RICH PROTEIN 
MAY 2013 
MYLENE CASTELL FERROLINO 
B.S. UNIVERSITY OF THE PHILIPPINES 
M.S., UNIVERSITY OF THE PHILIPPINES 
PH.D., UNIVERSITY OF THE MASSACHUSETTS 
Directed by: Professor Lila M. Gierasch 
 
 
Protein aggregation has been implicated in several catastrophic diseases 
(neurodegeneration, diabetes, ALS) and its complexity has also become a major 
obstacle in large-scale production of protein-based therapeutics. Despite the generic 
behavior of proteins to aggregate, only a few globular proteins have known aggregation 
mechanisms. At present, there have been no clear connections between protein folding, 
function and aggregation. We have tackled the challenge of understanding the links 
between a protein’s natural tendency to fold and function with its propensity to misfold 
and aggregate. Using a predominantly β-sheet protein whose in vitro folding has been 
explored in detail: cellular retinoic acid-binding protein I (CRABP 1), as a model, we 
investigated sequence determinants for folding and aggregation. In addition, we 
characterized the aggregation-prone intermediate under native conditions. Our studies 
revealed similar contiguous aggregation cores in in vitro and in vivo aggregates of 
CRABP 1 validating the importance of sequence information under extremely different 
conditions. Hydrophobic stretches that comprise the interface in aggregates include 
  
viii 
residues surrounding the ligand binding portal and residues at the C-terminal strands of 
CRABP 1. Folding studies reveal that docking of the N and C terminals happen in the 
early stages of barrel closure of CRABP 1 emphasizing the role of folding in preventing 
exposure of risky aggregation-prone sequences. We further examined the intermediate 
that initiates aggregation under native conditions. We found that inherent structural 
fluctuations in the native protein, relevant to ligand binding of CRABP 1, expose 
aggregation-prone sequences. Binding of the ligand, retinoic acid decreases the 
aggregation of CRABP 1 illustrating the contribution of functional interactions in avoiding 
aggregation. Our study implies that because of the evolutionary requirement for proteins 
to fold and function, aggregation becomes an unavoidable risk. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
1.1.  Competitive Interactions in Protein Folding and Aggregation 
 
Proteins have encoded in their amino acid sequence highly feasible interactions 
that direct folding into their lowest energy three-dimensional functional state. The 
intrinsic property of proteins to achieve a shape that is thermodynamically stable has 
been originally demonstrated in Christian B. Anfinsen’s experiment where the unfolded 
protein spontaneously re-acquires its three-dimensional structure upon removal of 
denaturant (Anfinsen, 1973). At infinite dilution, intramolecular contacts leading to 
natively folded proteins are highly favored. Nonetheless, above infinite dilution, folding 
competes with stable intermolecular contacts leading to oligomers and aggregates.  
 
Proteins are able to fold efficiently in a biologically suitable timescale despite the 
enormous conformational space that a protein can sample under a given condition 
(Bartlett & Radford, 2009). The paradox between the time required for random unbiased 
conformational search to achieve the native state and the folding time of proteins can be 
explained by the existence of well-defined pathways (Karplus, 1997, Bartlett & Radford, 
2009). Dill and Chan have described the protein folding framework using folding not only 
as two dimensional pathways but as multi-dimensional funnels and free energy 
landscapes (Figure 1) (Dill & Chan, 1997). Folding free energy landscapes describe the 
narrowing of conformational space of the unfolded state in a downward direction to the 
lowest free energy native state (Dill & Chan, 1997). Robust folders containing naturally 
selected amino acid sequences are viewed as smooth funnels (Dill & Chan, 1997). On 
the other hand, proteins with more complex folding pathways are represented with 
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rugged energy landscapes containing kinetically trapped intermediates. The hierarchy of 
local minima represents bottleneck conformations of either on-pathway or off-pathway 
intermediates (Dill & Chan, 1997, Milanesi, et al., 2012). The ability to surmount the 
energy barriers associated with kinetic traps dictates the rate of folding of a protein.  
 
Energy landscapes are not only used to describe protein folding but protein 
motions as well. Although the native state is illustrated as the single lowest energy 
minima in a folding landscape, a closer examination reveals multiple low-barrier energy 
wells representing populations in the native state ensemble (Frauenfelder, et al., 1991, 
Frauenfelder, et al., 2007). These conformations are thermodynamically distinct but 
structurally similar (Chiti & Dobson, 2009). Structural fluctuations have been associated 
with biological functions of proteins and thus are very important aspects in the study of 
proteins. “Breathing” motions of proteins have recently been linked to aggregation. In 
Chapter 3 of this thesis, we will describe protein dynamics in more detail including its 
coupled contributions to function and aggregation.  
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Figure 1.1. Example of free energy landscape for folding of proteins. Folding of 
proteins can be illustrated from physical point of view using energy funnels. Multi-state 
folders are represented with rugged energy landscapes containing several energy 
minima portraying kinetically trapped intermediates. Energy barriers govern the rate of 
protein folding. This figure is re-printed from Ken Dill’s website: 
http://dillgroup.stonybrook.edu/energy-landscapes. 
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The primary sequence of a protein defines its energy landscape and its path to 
the native state. However, the amino acid sequence also encodes the protein’s ability to 
form intermolecular contacts required for functional oligomerization or dysfunctional 
aggregation. The burial of hydrophobic segments in a native protein and in surfaces 
stabilizing protein aggregates suggests common physico-chemical constraints governing 
both folding and aggregation (Linding, et al., 2004, Routledge, et al., 2009). Hence, an 
integrated energy landscape for folding and aggregation is necessary to predict the fate 
of a polypeptide chain. Under finite dilutions, intramolecular associations leading to 
stably folded states compete with intermolecular contacts that lead to functional or non-
functional oligomers or highly stable insoluble aggregates. This can be envisioned as 
overlapping energy landscapes for folding and aggregation (Figure 1. 2) (Clark, 2004, 
Hartl & Hayer-Hartl, 2009). Energy wells in the folding landscape represent 
intermediates where destabilizing conditions can overcome an energy barrier and 
access the aggregation landscape (Clark, 2004, Hartl & Hayer-Hartl, 2009). As a 
consequence the equilibrium is pulled into the extremely stable aggregated state. 
Energy landscapes suggest correlation between thermodynamic stabilities and 
aggregation propensities and their dependence on the kinetic barriers that separate the 
states (Agostini, et al., 2012). Thus, changes in the folding energy landscape from 
destabilizing mutations or alterations in solution conditions (pH, temperature, ionic 
strength, pressure) may increase the aggregation propensity (Linding, et al., 2004). 
There is however growing evidence, suggesting aggregation of proteins may occur 
under native conditions which do not require significant destabilization of proteins (Chiti 
& Dobson, 2009). Structural fluctuations result in an ensemble of native-like species 
described in multiple low energy barriers. Low populations of slightly higher energy 
states can derail folding and lead to aggregation (Neudecker, et al., 2012). 
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Figure 1.2. Schematic integrated folding and aggregation energy landscape of 
proteins. Similar physico-chemical properties that govern intramolecular and 
intermolecular contacts result in an overlap (purple) in energy landscapes for folding 
(blue) and aggregation (red). Wells on energy landscapes represent kinetically trapped 
intermediates - on-pathway (Ion), off-pathway (Ioff) or near native (N*) intermediates, that 
can lead either to natively folded proteins or aggregates.  
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1.2.  Characteristics of Protein Aggregates 
 
Aggregation is a concentration-dependent self-assembly of misfolded proteins 
yielding either highly ordered or amorphous insoluble deposits (Sugiyama, et al., 2010). 
Protein aggregation typically results in loss-of-function or a gain-of-function resulting to 
cellular toxicity. For decades, huge interest in understanding protein aggregation has 
been attributed to its direct implications in serious diseases. Cellular protein aggregates 
are highly abundant in several neurodegenerative diseases (e.g. Alzheimer’s diseases, 
Parkinson’s disease and Huntington’s disease), prion-related diseases (Creutzfeldt-
Jacob disease and kuru), type 2 diabetes, hemodialysis related diseases, inherited 
cataracts and amyloidosis (Chiti & Dobson, 2006). From a cellular point of view, toxicity 
derived from aggregation is linked to obstruction of the protein quality control 
machineries, which include molecular chaperones and proteases, depletion of essential 
proteins and build-up of toxic polypeptides (Sanchez de Groot, et al., 2012). However, 
aggregation is not only associated with pathological conditions but can be beneficial as 
well. Under highly regulated conditions several organisms are able to exploit aggregation 
for function. Functional aggregates are exemplified in the case of an E. coli protein, 
curlin, found to be essential in colonizing inert surfaces, forming biofilms and mediating 
host protein binding (Chapman, et al., 2002). Functional aggregates are also found in 
higher organisms such as aggregates formed by the protein Pmel17 involved in melanin 
production (Berson, et al., 2003). Peptide and protein hormones are also stored in cells 
in the form of protein aggregates (Maji, et al., 2009). In addition, aggregates also 
function as inheritable non-chromosomal genetic elements which is exhibited by prion 
protein aggregates (Wickner, et al., 2013).  
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The most characterized forms of protein aggregates are the highly structured 
amyloid fibrils. Amyloids consist of repeated β-strands that run perpendicular to the fiber 
axis assembling into stacked cross-β sheets (Tycko, 2006). These very stable amyloid 
“cores” are highly solvent protected and protease resistant (Hoshino, et al., 2002, Frare, 
et al., 2006). Interestingly these stable aggregation cores are only comprised of very 
short (5-15 residues) hydrophobic and low charged segments (Chiti, et al., 2003, 
Fernandez-Escamilla, et al., 2004, Beerten, et al., 2013). Aggregation cores are typically 
made up of amino acids with aliphatic side chains (valine, leucine and isoleucine) and 
aromatic side chains (Sanchez de Groot, et al., 2012). Amyloid fibrils contain rope-like 
structures of twisted protofilaments (Sunde, et al., 1997, Serpell, et al., 2000). The 
regular cross-β cores of amyloids specifically bind to congo red and thioflavin T (LeVine, 
1999, Westermark, et al., 1999, Biancalana & Koide, 2010). Amyloids are formed via an 
initial nucleation lag phase involving the population of a rare misfolded intermediate, 
followed by a rapid exponential growth phase, where monomers or oligomers associate 
with the nucleus (Chiti & Dobson, 2006).  
 
In contrast to amyloids, the mechanism of amorphous aggregation is less 
explored. Amorphous aggregates have been of significant interest in the microbiology 
and biotechnology fields as these are commonly found in bacterial inclusion bodies 
during over-expression of heterologous proteins (de Groot, et al., 2008). Despite the 
non-fibrillar, amorphous appearance, several studies revealed presence of ordered 
amyloid-like core structures in bacterial inclusion body deposits (Carrio, et al., 2005, 
Wang, et al., 2008, de Groot, et al., 2009). Interestingly, globular proteins in these 
bacterial aggregates are still able to retain their functional native-like conformations 
(Garcia-Fruitos, et al., 2005, Ventura & Villaverde, 2006). Recently, amorphous 
aggregates have also been implicated in diseases such as in aggregated lenticular αB-
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crystallins in cataracts (Sugiyama, et al., 2010). Furthermore, prefibrillar aggregates that 
are currently argued to cause toxicity in amyloid diseases appeared amorphous 
(Dobson, 2003, Meredith, 2005). The kinetics of amorphous aggregation is proposed to 
be similar to a glass transition (Yoshimura, et al., 2012). Glass-like properties in 
amorphous aggregates observed swap domains and restructure into stable species 
during intense salting-out (Yoshimura, et al., 2012). This suggested the possible role of 
amorphous aggregation as a preliminary step towards amyloid formation (Yoshimura, et 
al., 2012). It has been shown that under defined conditions proteins either form amyloids 
and amorphous aggregates or both (Morshedi, et al., 2010). Although the morphologies 
of aggregates may vary within the same or across different proteins, stretches engaging 
in stabilization of aggregates have similar properties. Experimentally determined 
properties of aggregation prone segments can be used to train algorithms for forecasting 
aggregation tendencies. Thus, sequence-based predictions for aggregation have been 
useful tools in screening aggregation-prone segments and evaluating aggregation 
propensities for a large number of proteins.  
 
1.3.  Prediction of Aggregation-Prone Sequences Proteins 
 
A protein’s thermodynamic stability, structural class and amino acid sequence of 
proteins all govern aggregation propensities. (Conchillo-Sole, et al., 2007, Niwa, et al., 
2009, Tartaglia & Vendruscolo, 2010, Agostini, et al., 2012). However, there is not a 
huge amount of information available on stabilities of proteins. We also do not know 
much about the aggregation propensities of different structural classes. Hence, 
correlating aggregation with amino acid sequences is the only convenient way to provide 
initial clues on the aggregation tendencies of proteins. Furthermore, we can apply these 
to find relationships for natural selection and to optimize conditions in controlling self-
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assembly. Several aggregation prediction algorithms have been developed over the 
years that exploit the plethora of studies on experimentally identified residues of proteins 
participating in aggregation. These algorithms aimed to distinguish short specific amino 
acid stretches engaging in aggregates and predict overall aggregation propensities of 
proteins. At present these have been used to forecast aggregation propensities for an 
enormous number of proteins both in bacterial and eukaryotic proteomes (de Groot & 
Ventura, 2010, Tartaglia & Vendruscolo, 2010, Grana-Montes, et al., 2012). Here we will 
briefly describe experimentally validated aggregation predictors namely, AGGRESCAN, 
PASTA, TANGO and Zyggregator that we used in the study.  
 
AGGRESCAN predicts “aggregation hotspots” based on hydrophobicity, β-sheet 
propensity and charge of amino acid side chains (de Groot, et al., 2006, Conchillo-Sole, 
et al., 2007). Aggregation propensities are calculated from the analysis of single residue 
substitutions in an aggregation-prone sequence (the hydrophobic cluster of Aβ) in the 
context of the full-length polypeptide (GFP fusion acting as an aggregation reporter) and 
not as an isolated short peptide (Conchillo-Sole, et al., 2007). The calculations are 
based on previously determined aggregation-propensity values per amino acid (a3v) 
averaged over a sliding window of a given length (a4v) (Conchillo-Sole, et al., 2007). A 
region in the polypeptide sequence is considered an aggregation "hot spot" (HS) if there 
are five or more contiguous residues (none is a proline) with an a4v larger than the HST 
("hot spot" threshold defined as the average of the a3v of the 20 amino acids weighted 
by their frequencies in the SwissProt)(Conchillo-Sole, et al., 2007). AGGRESCAN has 
been used in analyzing the aggregation propensities of protein kinase sequences in 
human and other organisms to identify evolutionary pressures in this family of proteins 
(Grana-Montes, et al., 2012). This method has also been exploited to find associations 
between aggregation propensity with length, conformation, location, function, and 
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abundance in cells (de Groot & Ventura, 2010). AGGRESCAN has been found to be 
consistent with other aggregation predictors (de Groot & Ventura, 2010).  
 
TANGO predicts β-aggregation in peptides and proteins based on a phase-space 
covering major conformational states, namely the folded state, β-sheet, β-turn, α-helix 
and β-aggregate (Fernandez-Escamilla, et al., 2004). Segments of a peptide can 
populate each of these states following the Boltzmann distribution. Prediction of 
aggregation segments by TANGO is simply calculating the partition function of the 
phase-space (Fernandez-Escamilla, et al., 2004). TANGO has been previously used in 
studying structural properties and mutational effects linked to aggregation (Linding, et 
al., 2004). TANGO has also been used analyze several proteomes to find evolutionary 
pressures that minimize aggregation (Rousseau, et al., 2006, Chen & Dokholyan, 2008).  
 
PASTA calculates aggregation propensities based on similar parameters such as 
β-propensity, hydrophobicity and charge of amino acid side chains. However PASTA can 
also predicts the registry of the intermolecular hydrogen bonds formed between amyloid 
sequence stretches (Trovato, et al., 2006). This is useful in envisioning the orientation of 
β-strands in the aggregation cores with respect to each other.  
 
Zyggregator, similar to all other aggregation prediction algorithms, takes into 
account the hydrophobicity and secondary structure propensities of the amino acid side 
chains to predict differential aggregation behaviors between polypeptides (Tartaglia & 
Vendruscolo, 2008). In addition to this, Zyggregator also considers the intrinsic 
aggregation propensity and the stability of a polypeptide to have a significant tendency 
to form intermolecular interactions (Tartaglia & Vendruscolo, 2008). Aggregation 
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propensities are reported as Zagg. Zyggregator has been employed to identify key 
regions in proteins that affect aggregation rates (Routledge, et al., 2009). Also, it has 
also been used to predict relationships of aggregation propensity with evolutionary 
constraints at a proteome level (Tartaglia & Vendruscolo, 2010).  
1.4.  Aggregation Mechanisms of Globular Proteins 
 
Despite the generality of aggregation in proteins and the abundance of 
aggregation-prone proteins in vivo, only a handful of globular proteins have well-
described aggregation mechanisms. Originally, it was recognized that aggregation 
requires population of alternative protein conformations characterized by partially or 
globally unfolded intermediates that transitions the native state over a high-energy 
barrier of unfolding (Kelly, 1996, Chiti & Dobson, 2009). At conditions that favor 
aggregation such as low pH, high temperature, high pressure, presence of co-solvents 
or destabilizing mutations, the free energy of native state is increased relative to the 
unfolded and intermediate states hence increasing the populations of these states (Chiti 
& Dobson, 2009). When there is none or very minimal change in the free energy of the 
transition state, then the native state will have increased kinetic accessibility to the 
unfolded and intermediate states (Chiti & Dobson, 2009). Thus, population of these high 
energy misfolded species promotes aggregation (Chiti & Dobson, 2009). Several 
proteins have demonstrated tendencies to aggregate from a disordered state for obvious 
reasons that aggregation-prone segments are exposed when unfolded. These have 
added interest in the study of intrinsically disordered proteins (IDPs) in aggregation.  
 
Some examples of proteins with partially unfolded aggregation-prone 
intermediates identified include β2-microglobulin (β2m), lysozyme, transthyretin and 
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copper-zinc superoxide dismutase I (SOD I). β2-microglobulin, a 99 residue β-sandwich 
protein deposited in the joints of patients suffering from dialysis related amyloidosis was 
shown to aggregate in an acidic solvent (Platt & Radford, 2009). A 10-residue aromatic 
rich amino acid stretch which controls the rate of aggregation of β2m is found to be 
exposed in the a partially unfolded intermediate at low pH (Platt & Radford, 2009). 
Human wild-type lysozyme at pH 5 and its mutants form molten globule-like 
intermediates during aggregation (Booth, et al., 1997). In case of transthyretin, 
aggregation accedes via a partially denatured monomer at conditions that mimic the pH 
of the lysosome (Colon & Kelly, 1992). Several mutations in copper-zinc SOD I that lead 
to amyotrophic lateral sclerosis significantly destabilize the β-barrel and dimerization 
interfaces leading to aggregation (Perry, et al., 2010).  
 
As mentioned earlier, there is a growing number of proteins demonstrating 
aggregation without largely changing their conformation and surpassing high energy 
barriers (Kelly, 1996, Kelly, 1998, Jahn, et al., 2006, Chiti & Dobson, 2009, Neudecker, 
et al., 2012). Conformations of aggregation-prone states can be thermodynamically 
distinct but almost structurally identical to the native state. These native-like or N* states 
are accessed from the native state through thermal fluctuations (Chiti & Dobson, 2009). 
N* states are at higher energy than the native proteins, but are only separated by a 
relatively low energy barrier (Chiti & Dobson, 2009). Interestingly, globular proteins 
under extremely different conditions (destabilizing or native conditions) contain the same 
driving hydrophobic sequences to produce similar types of aggregates (Calamai, et al., 
2005). This is consistent with proteins possessing rugged aggregation energy 
landscapes consisting of structurally diverse precursors.  
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The proteins mentioned earlier alternatively aggregate at near physiological 
conditions. A rarely populated native-like intermediate of β2-microglobulin containing a 
non-native trans-proline isomer is found to favor aggregation (Eakin, et al., 2006, Jahn, 
et al., 2006). Edge strands of β2m that normally protect β-sandwich proteins from self-
association are perturbed in the aggregation precursor (Jahn, et al., 2006). Inherent 
fluctuations associated with the native state also lead to aggregation of the mutant 
lysozyme proteins (Chiti & Dobson, 2009). The aggregation-prone intermediate is a 
partially unfolded state formed through a locally cooperative process and a conformation 
thermodynamically distinct from the native state, but still on the native side of the free 
energy barrier for unfolding (Chiti & Dobson, 2009). In the case of copper-zinc SOD I, a 
metal and non-metal bound mutant S134N populates a near native intermediate that 
permits transient soluble oligomers through an unfolded loop VII or electrostatic loop 
leading to aggregation (Banci, et al., 2005). Transthyretin aggregates under native 
conditions when the monomer undergoes local unfolding of peripheral strands yielding 
exposed aggregation-prone β-strands (Olofsson, et al., 2004). Proteins like insulin and 
acylphosphatase (AcP) from Sulfolobus solfataricus form native-like α-helical oligomeric 
precursors that later undergo global structural reorganization to form amyloids 
(Bouchard, et al., 2000, Chiti & Dobson, 2009). The growing evidence suggesting that 
proteins apparently access aggregation-prone conformations that are near-native 
indicates that the folded state remains at risk of aggregation.  
1.5.     Protein Folding and Aggregation in the Cell  
It is imperative to note that events observed in vitro do not fully recapitulate 
folding and aggregation in the complex environment of the cell. Thus, what we learn in 
vitro from a few model proteins is only seeing the tip of the iceberg. In vivo conditions 
pose several challenges in predicting the fate of a protein. In the cell, newly synthesized 
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polypeptides vectorially emerge from the ribosome permitting the N-terminal segments 
of the protein to encounter an extremely complex and crowded environment during 
folding that can exacerbate aggregation (Ellis & Minton, 2006, Gershenson & Gierasch, 
2011, Zhang & Ignatova, 2011). In addition, the protein load in cells that needs to fold is 
relatively large. It is estimated that 10-20% of residues in proteomes from prokaryotic 
and eukaryotic organisms are aggregation-prone (Rousseau, et al., 2006). Although 
macromolecular crowding is biased towards more compact states like the native fold, it 
also favors specific and nonspecific intermolecular associations (Gierasch & 
Gershenson, 2009). Inside the cell protein mobilities are also hindered, increasing the 
chances for productive and non-productive encounters. In addition, macromolecular 
crowding affects the viscosity of the protein environment thus affecting their folding rates 
and mechanism (Gershenson & Gierasch, 2011). Increased risk of aggregation caused 
by macromolecular crowding in the cell emphasizes the critical role of folding assistants 
or molecular chaperones and efficient degradation machineries (Ellis & Minton, 2006, 
Gershenson & Gierasch, 2011, Vendruscolo, 2012). This evolutionarily conserved 
network of chaperones and proteases provides immediate cellular counter measures to 
environmental stress in order to maintain protein homeostasis also known as 
“proteostasis” (Hartl, et al., 2011, Powers & Balch, 2013). However, their roles in 
assisting de novo folding and refolding have also been recognized under non-stressed 
conditions (Richter, et al., 2010). In fact, there are a remarkable number of proteins 
highly dependent on chaperones (Kerner, et al., 2005, Niwa, et al., 2009, Fujiwara, et al., 
2010, Calloni, et al., 2012). Molecular chaperones remodel the energy landscape of 
proteins to favor productive folding over aggregation (Hartl, et al., 2011). There are five 
major classes of molecular chaperones, which include: Hsp100s, Hsp90s, Hsp70s, 
Hsp60s (chaperonins), and small heat shock proteins. These proteins either recognize 
unfolded proteins to assist folding, bind native proteins to facilitate functions or disrupt 
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insoluble aggregates (Richter, et al., 2010). Molecular chaperones either enclose 
unfolded proteins in a chamber to actively or passively assist folding as in the case of 
Hsp60 or protect hydrophobic stretches from exposure as in the case of Hsp 70 (Zhu, et 
al., 1996, Hartl, et al., 2011, Clare, et al., 2012). Hsp 90 assists in the late stage 
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 ! !   	 Molecular chaperones work 
simultaneously in an intricate network with proteases that degrade misfolded adds to the 
increasing complexity of competing interactions with the polypeptide chain (Powers, et 
al., 2012). Thus, it remains an enormous challenge to understand protein folding in the 
cell. 
1.6. Statement of Dissertation 
Despite the vast amount of information that is available, there is a lack of a 
holistic view of the entwined folding and aggregation energy landscapes. Fundamental 
questions continue to confound us: What are the sequence features of a polypeptide that 
link folding and aggregation? Are mechanisms of aggregation observed in vitro 
maintained in vivo? In addition, there has been very scarce evidence linking aggregation 
propensity and evolutionary requirement to function. Hence we also ask: What can be 
learned from our model protein CRABP 1 which has utilized several mechanisms to 
avoid aggregation? How do inherent protein motions associated with function endanger 
proteins towards aggregation? How do functional interactions offset aggregation 
propensity? What are the cellular mechanisms that modulate aggregation without 
compromising functions? 
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In Chapter 2 of this thesis, sequence determinants that drive in vitro and in vivo 
aggregation of CRABP 1 were explored. Here, CRABP 1 will be presented as an 
excellent model to study aggregation revealing conserved residue stretches that drive 
aggregation in vitro and in vivo. Furthermore, our findings will illustrate how critical amino 
acid segments expose mechanistic linkages between folding and aggregation of CRABP 
1. In Chapter 3, we will present extensive work done to characterize the molecular basis 
of aggregation of CRABP 1 under native conditions. This chapter will describe findings 
supporting intimate connections between a low-population intermediate closely 
resembling the functional conformation and the tendency to aggregate. We will also 
describe existing intrinsic and extrinsic protection mechanisms against protein 
aggregation. The final chapter will provide a summary of what we have learned about 
the aggregation mechanism of CRABP 1 under native conditions, its implications in the 
cellular context, and further discuss directions currently being undertaken to explore the 
entire aggregation energy landscape of CRABP 1.  
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CHAPTER 2 
 
AGGREGATION SEQUENCE DETERMINANTS: IMPLICATIONS FOR FOLDING OF 
A β-RICH PROTEIN 
 
This chapter describes results of collaborations with Anastasia Zhuravleva, Ivan Budyak, 
Beena Krishnan, Annie Marcelino and Lila Gierasch [Publication: Budyak I.L., Krishnan 
B., Marcelino-Cruz A.M., Ferrolino M.C., Zhuravleva A. & Gierasch L.M. (2013) Early 
Folding Events Protect Aggregation-Prone Regions of a β-Rich Protein. Structure 21: 
476-485. 
 
2.1. Introduction 
Competition between folding and aggregation is imminent in proteins with rugged 
energy landscapes such as β-sheet rich proteins. β-sheet rich proteins have complex 
topologies and exhibit high degrees of energetic frustration. Intracellular lipid binding 
proteins (ILBPs) are a family of proteins with frustrated energy landscapes yet have not 
been implicated in any misfolding diseases (Budyak, et al., 2013). Over the past 
decades cellular retinoic acid binding protein (CRABP 1), a member of the ILBP family 
has been used as an excellent model to study the folding and aggregation of β sheet-
rich proteins (Liu, et al., 1994, Clark, et al., 1996, Clark, et al., 1997, Clark, et al., 1998, 
Eyles, et al., 1999, Rotondi & Gierasch, 2003, Ignatova & Gierasch, 2004, Ignatova & 
Gierasch, 2005, Ignatova & Gierasch, 2006, Marcelino & Gierasch, 2008, Ignatova & 
Gierasch, 2009, Budyak, et al., 2013). However, similar to other proteins, a link between 
these two distinct overlapping processes is not yet established. This chapter will present 
findings from the experiments we carried out with an aim to fill the gap in knowledge 
between folding and aggregation of CRABP 1. We will show common sequences in our 
model protein that are critical for both folding and aggregation. Furthermore, we will 
demonstrate how in the case of CRABP 1 physico-chemical properties required for 
aggregation in vitro are maintained in vivo and validate predictions offered using several 
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aggregation algorithms. Finally, this chapter will create an integrated picture describing 
how key sequence features in CRABP 1 that direct aggregation are protected early by 
folding. 
 
2.1.1. Structure, Function and Dynamics of CRABP 1 
 
CRABP 1 is a 136-residue β-sheet-rich protein and a member of the ILBP family. 
Its proposed role in the cell is to control the nuclear uptake of retinoic acid at different 
stages of development (Donovan, et al., 1995). Like other ILBPs, CRABP 1 has a β-
barrel structure made up of two orthogonal five stranded β-sheets with an open angle 
between and two helices that connect strands 1 and 2 (Kleywegt, et al., 1994, 
Thompson, et al., 1995) (Figure 2.1). Except for strands 5 and 6, which are connected 
by a variable Ω-loop, other β-strands are linked by short reverse turns (Kleywegt, 
Bergfors et al. 1994). A hydrogen bond ladder stabilizes the β-strands in the barrel and 
is broken between strands 4 and 5 (Thompson, Bratt et al. 1995). Like other ILBPs, it 
forms a ligand binding solvent-shielded cavity filled with ordered water (Kleywegt, et al., 
1994, Thompson, et al., 1995). Retinoic acid is sequestered in the barrel by hydrophobic 
interactions with helix 2, turn 2 (between strands 3 and 4), turn 4 (between strands 5 and 
6) and polar interactions at the innermost cavity making the barrel almost inaccessible 
(Kleywegt, et al., 1994, Li, 1999). The helix-turn-helix structural motif acts as lid that 
opens up a dynamic portal between turns 2 and 4, allowing ligand entry and egress 
(Thompson, et al., 1995, Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Binding of 
retinoic acid reduces the dynamics of this portal and locks the ligand inside the protein. 
In chapter 3, we will discuss the structurally dynamic behavior of CRABP 1 and other 
ILBPs that engages in ligand binding.  
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Figure 2.1. Two projections of the structure of cellular retinoic acid binding 
protein 1 (CRABP 1) bound to retinoic acid. CRABP 1 consists of two anti-parallel five 
stranded β-sheets forming a large ligand binding cavity and connected by a helix-turn-
helix motif. Turn II connecting strands 3 and 4 and turn 4 which links strand 5 and 6 
interact with the helical region and form the ligand portal site. (PDB ID: 1CBR )  
(Kleywegt, G. J., T. Bergfors, et al. (1994). "Crystal structures of cellular retinoic acid 
binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid." 
Structure 2(12): 1241-1258) 
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2.1.2. Folding and Aggregation of CRABP 1 
 
CRABP 1 has been used as a suitable model protein for understanding the 
folding and aggregation landscapes of β-sheet proteins (Clark, et al., 1998, Ignatova & 
Gierasch, 2005, Ignatova, et al., 2007). CRABP 1 like other ILBPs has a rugged folding 
landscape, which has been described over the years using a wide array of biophysical 
techniques such as intrinsic tryptophan fluorescence, ANS binding and circular 
dichroism methods (Clark, et al., 1996, Clark, et al., 1997, Clark, et al., 1998). CRABP 1 
folds via three well-defined kinetic phases. The initial phase is characterized by a rapid 
hydrophobic collapse (τ=250 µs) where local segments of chain adopt significant 
secondary structure (Clark, et al., 1997). This is followed by the establishment of specific 
interactions that restrict the arrangement of the chains into a native topology (τ=100 
ms)(Clark, et al., 1998). The final phase (1s) consists of specific packing of the β-sheet 
side chains and formation of stable inter-strand hydrogen bonding (Clark, et al., 1998) 
(Figure 2.2). 
 
As mentioned earlier despite the high beta sheet content and the ruggedness of 
folding landscapes, CRABP 1 and other ILBPs have not been associated with any 
misfolding diseases. This observation implies that this class of proteins may have 
evolved this robust folding mechanism with built-in aggregation protection (Budyak, et 
al., 2013). Although CRABP 1 is found to be a successful folder, we have the capacity to 
explore its aggregation landscape by introduction of single residue substitutions on 
CRABP 1 or by modest alterations in solution conditions (addition of low concentrations 
of denaturant or at slightly acidic pH). Previously, it has been found that in vitro and upon 
overexpression in E. coli, CRABP 1 mutants form amorphous aggregates containing β-
lamellar structures with 10.03Å spacing between adjacent beta-sheets as revealed by 
wide-angle X-ray scattering (WAXS) (Ignatova & Gierasch, 2004, Ignatova, et al., 2007). 
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CRABP 1 folding and aggregation in E. coli have been monitored using a real-
time fluorescence labeling method (Ignatova & Gierasch, 2004). This strategy involves 
incorporation of structurally non-perturbing, specific tetra-Cys binding site for a bis-
arsenical fluorescein-based dye FlAsH that reports the folding and solubility of the 
protein (Ignatova & Gierasch, 2004). Using this approach, aggregation of various 
CRABP 1 mutants was monitored (Z. Ignatova & L. Gierasch, unpublished). Aggregation 
of a slow-folding CRABP 1 mutant (Ignatova & Gierasch, 2005) showed similarities to 
amyloids, following a nucleation-dependent polymerization requiring the formation of an 
energetically unfavorable nucleus. (Ignatova & Gierasch, 2005, Ignatova, et al., 2007). 
However, we have not yet fully understood the molecular basis of aggregation 
propensity of CRABP 1. With the growing number of aggregation-prone mutants of 
CRABP 1 being identified in the lab, we have been equipped to explore sequences that 
determine the tendency of CRABP 1 to aggregate (Z. Ignatova and L. Gierasch, 
unpublished). In the following section, we will describe hydrogen exchange experiment 
we have utilized to identify regions sequestered in CRABP 1 aggregates. 
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Figure 2.2. Folding pathway of CRABP 1. The proposed folding pathway for CRABP 1 
proceeds through an early hydrophobically collapsed to form intermediate, I1 (τ= 
~250 µs); followed by formation of I2 which has the native topology and ligand binding 
cavity (τ= ~100 ms); and then by establishment of a hydrogen-bonding network and 
specific tertiary interactions to form the native state, N (τ= ~1 s). 
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2.1.3. Hydrogen-Deuterium Exchange NMR to Map Aggregation Cores 
 
Short segments of a protein of at least five amino acid residues are sufficient to 
form ordered aggregates (Chiti, et al., 2003, Fernandez-Escamilla, et al., 2004). These 
segments have strong propensities to exhibit cross-β structures in aggregates and are 
highly occluded from the environment (Hoshino, et al., 2002, Frare, et al., 2006). 
Aggregation core sequences have been identified experimentally using methods that 
probe for solvent accessibility as well as protease resistance (Hoshino, et al., 2002, 
Frare, et al., 2006, Wang, et al., 2008, Vilar, et al., 2012). Amide hydrogen deuterium 
exchange (HX) has been used to map core segments of β2m (Hoshino, et al., 2002), 
transthyretin (Olofsson, et al., 2004), Aβ peptide (Kheterpal, et al., 2006) amyloids as 
well as of bacterial inclusion bodies (Hoshino, et al., 2002, Olofsson, et al., 2004, 
Kheterpal, et al., 2006, Vilar, et al., 2012). This method sensitively probes for highly 
ordered regions of the protein molecule forming amyloid fibrils at amino acid residue 
resolution. In this thesis we have successfully employed hydrogen exchange in resolving 
aggregation core sequences of CRABP 1. 
 
Hydrogen deuterium exchange measures the rate of exchange between the 
amide hydrogen in the polypeptide backbone and deuterium in the solvent. Exchange 
rates can be monitored using available methods that can distinguish between proton and 
deuterium such as nuclear magnetic resonance (HX-NMR) and mass spectrometry (HX-
MS) (Scholtz & Robertson, 1995, Hoofnagle, et al., 2004). Measurements of exchange 
rates can unveil the presence or absence of protecting structure thus are valuable in 
determining thermodynamic stability, studying protein dynamics and following protein 
folding (Eyles & Kaltashov, 2004, Krishna, et al., 2004). Amide hydrogens in an unfolded 
polypeptide are labile and exchange readily with the solvent. On the other hand, in 
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folded proteins where secondary and tertiary structures prevail, exchange is retarded by 
H-bonding networks or by burial of hydrophobic residues in the core of a protein. The 
extent of protection from exchange in the folded protein correlates with the degree of 
ordered structures.  
Hydrogen exchange consists of two steps: First is the exposure of backbone 
amides to the solvent by reversible unfolding of the protein. Second is exchange 
between deuterium from the solvent and the exposed amide protons. The overall 
exchange kinetics are governed by both reactions.  
 
NHc and NHo represent the amide groups in the “closed” (folded) and “open” (unfolded) 
ND is the exchanged amides; The measured exchange rate kex is determined by the 
opening ko, closing kc rate constants and the expected rate of exchange assuming the 
site is completely exposed, kint. The relationship is shown as: 
 
Under conditions where HX is generally performed, the kc >>ko to approximate 
the previous equation as: 
 
There are two extreme limits of exchange EX1 and EX2. The first case is when kc
>> kint, an behavior expected at low pH and temperature, the exchange rate becomes: 

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where Ko = ko/kc. This is an EX2 or bimolecular exchange limit. A heterogeneous pattern 
of exchange results from incomplete exchange at all sites. The second case is when kc 
<< kint, all protons in the unfolded segment will exchange, in this case, unfolding of the 
protein is a rate-limiting step thus, 
kex =ko 
This limit of exchange is referred to as EX1 or monomolecular exchange. EX1 
appears as a bimodal pattern with all amides either exchanged or unexchanged. This is 
usually observed at high pH and temperature the exchange reaction rate is limited by the 
opening event of the amide site. 
 
Hydrogen exchange combined with high-resolution NMR spectroscopy provides 
detailed information on the structure and thermodynamic stability of proteins at residue-
specific resolution. This method has been widely applied in probing various 
conformational states of proteins, including denatured states, and equilibrium or kinetic 
folding intermediates with complex three-dimensional structure (Hoshino, et al., 2007). A 
typical HX-NMR experiment requires high concentrations of proteins in solution and an 
appropriate NMR measurement is recorded. Cross-peak intensities used to detect amide 
protons such as 1H-15N heteronuclear single quantum correlation (HSQC) directly 
correlates with the occupancy of amide protons. Exchange rates are determined by 
monitoring the decrease in peak intensity in the spectrum. A single exponential decay 
plot of peak intensity as a function of exchange time is generated as described in the 
equation: 
I(t) = I(0) exp(−kext) 
where t is the exchange time, I(0) and I(t) are peak intensity at time zero and time t, 
respectively, and kex is the exchange rate constant. 
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In a hydrogen exchange experiment protein samples are incubated in a 
deuterated solvent for a period of time followed by a quenching reaction at low pH and 
temperature. At low temperatures and pH, the rates of exchange are reduced preventing 
back exchange in deuterated amides. HX detection using solution NMR poses inherent 
limitation on the apparent size of the target protein in which signal is approximately 
inversely proportional to the molecular weight of the protein (Hoshino, et al., 2007). Line 
width broadening of NMR signal results from increase in rotational correlation time as 
molecular weight of the protein increases. Since the line widths are infinitely broadened 
for supramolecular complexes, direct measurement of NMR spectrum is impossible. 
Nevertheless, a modified hydrogen exchange NMR method has been developed to 
study the structural and dynamic properties of β-microglobulin and cold shock protein A 
(CspA) aggregates (Alexandrescu, 2001, Hoshino, et al., 2002). Despite the fact that this 
does not offer information about the geometric constraints of the aggregates, it provides 
details on structural reorganizations in the native protein accompanying aggregation 
(Vilar, et al., 2012). In addition it also allows identification of peptide segments involved 
in the formation of secondary structures that stabilize aggregates (Vilar, et al., 2012). An 
indirect HX technique uses an organic aprotic solvent dimethyl sulfoxide (DMSO) to 
quench exchange and dissolve aggregates in solution to permit analysis by solution 
NMR (Hoshino, et al., 2007). At very high DMSO concentrations, aggregates are 
dissolved into monomers within the dead time of NMR measurements (Hirota-Nakaoka, 
et al., 2003). The exact oligomeric state of the protein in DMSO is not known however no 
difference in line widths in the NMR spectra is evident between the monomer and 
dissolved aggregates (Hoshino, et al., 2007).  
 
The rate of exchange in DMSO is 100-fold lower in 90-95% DMSO than in water 
(Zhang, et al., 1995). Furthermore, pH dependent exchange is different in water and in 
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DMSO shifting the minimum from pH 3 to pH 5 (Zhang, et al., 1995). In DMSO, 
formation of deprotonated amide necessary in the base-catalyzed exchange is 
unfavorable resulting in this pH minimum shift (Zhang, et al., 1995). This also shifts the 
pKas of acids to a great extent whereby strong acids in aqueous solutions such as 
dichloroacetic acid (DCA) and trifluoroacetic acids may act as buffers in DMSO (Zhang, 
et al., 1995). DMSO not only dissolves aggregates but also offers as a solvent without 
labile hydrogens that may cause back-exchange. At high DMSO concentrations, 
solubilized proteins are denatured thus amide proton exchange for each residue is 
susceptible to exchange with trace water in the solvent. However, the rates of back-
exchange is reduced in high DMSO solvents thus permits acquisition of multiple HSQC 
spectra for analysis (Hoshino, et al., 2007).  
 
The steps for DMSO-quenched hydrogen exchange are as follows: 1) 
Preparation of aggregates in aqueous solution; 2) incubation of aggregates in deuterated 
buffer; 3) collection of aggregates at various exchange times; 4) exchange quenching 
and dissolution of aggregates at high (>95%) concentrations of DMSO-d6 at an 
appropriately adjusted pH value; 5) acquisition of two-dimensional NMR spectra 
successively to detect resonance signals from remaining protonated residues (Hoshino, 
et al., 2007).  
 
Several factors may interfere with this experiment. First is the fact that DMSO is 
an aprotic and hygroscopic solvent it is difficult to maintain pH and to prevent water 
contamination (Hoshino, et al., 2007). In addition even if water is completely eliminated, 
internal exchange between amide protons of residues may complicate the experiment 
(Hoshino, et al., 2007). To minimize the effect of water contamination it is recommended 
that 95% (v/v) DMSO-d6 and 5% (v/v) D2O at pD 5 adjusted by DCA-d2 be used as a 
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quenching buffer for the exchange reaction. The presence of residual exchange in 5% 
(v/v) of D2O is not expected to complicate the experiment as long as the rate of 
exchange and water contamination is very minimal (Hoshino, et al., 2007). 
 
2.2. Results 
 
2.2.1. Aggregation Propensity of CRABP 1  
 
In our study, we have used a stabilized variant of CRABP 1, WT* containing 
R131Q mutation. Mutation of Arg 131 breaks the charged interactions between retinoic 
acid leading to less affinity to the ligand (Zhang, et al., 1992). This variant has been 
previously used in understanding the folding landscape of CRABP 1 (Clark, et al., 1996, 
Clark, et al., 1998, Eyles, et al., 1999, Eyles & Gierasch, 2000, Marcelino & Gierasch, 
2008). While this mutant has a lower ligand binding affinity, it is more thermostable and 
highly soluble when over-expressed in E. coli. Thus, WT* CRABP 1 serves as a suitable 
background to monitor effects of residue substitutions or solution conditions on 
aggregation propensity.  
 
Using several available aggregation prediction algorithms namely, AGGRESCAN 
(Conchillo-Sole, et al., 2007, de Groot, et al., 2012), TANGO (Fernandez-Escamilla, et 
al., 2004), PASTA (Trovato, et al., 2006) and Zyggregator (Tartaglia & Vendruscolo, 
2008) aggregation hotspots in CRABP 1 were predicted (Appendix A). Predictions varied 
only slightly from one algorithm to another, as aggregation prone regions are usually 
predicted by at least two algorithms. Aggregation propensity scores have been 
consistently high in strands 3, 4, 9 and 10 and helix II (Figure 2.2a). 
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Figure 2.3 Predicted aggregation-prone regions of CRABP 1.  
 
A)  Predicted aggregation-prone regions using Zyggregator, AGGRESCAN, TANGO 
and PASTA mapped on to the sequence of CRABP 1. 
 
B) Aggregation-prone regions projected on to the structure of CRABP 1. Sequences 
predicted by at least two algorithms are painted in green. Sequences predicted by 
only one algorithm are painted in blue. All predictors identified the C-terminal 
strands to be aggregation prone. 
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WT* CRABP 1 can be overexpressed as soluble protein in E. coli, but we found a 
number of single residue substitutions that result in different extents to aggregate (Table 
2.1. The aggregation propensities of CRABP 1 variants were determined using cell 
fractionation method. This was accomplished by overexpressing mutant protein in 
BL21(DE3) E. coli strains at 37oC for 3 hours and then lysing the cells using a 
commercially available mild non-ionic detergent. Initial experiments to test the 
reproducibility of cell disruption techniques revealed that optimal lysis can be achieved 
without breaking the aggregates using this mild detergent as compared to sonication and 
freeze thaw methods. Following cell disruption, lysates were separated into supernatant 
and pellet fractions and run on an SDS-PAGE. The distributions between the soluble 
and pellet fractions of the protein were quantified by measuring the optical densities of 
protein bands corresponding to CRABP 1 and taking the ratio of the optical densities of 
the pellet and soluble fractions with respect to the lysate fraction (Table 2.1).  
 
To test whether aggregation propensities of the CRABP 1 mutants can be 
predicted, we again employed the aggregation predictors. We have found that except for 
a couple of mutants, aggregation predictors did not distinguish aggregation propensities 
between CRABP 1 variants with very different experimental aggregation propensities. An 
example is the case of F71A, which is a mutation in strand 5 and involved the 
hydrophobic core network of CRABP 1. We experimentally find this mutant to be highly 
aggregation-prone since it can only be expressed as inclusion bodies. However, all the 
aggregation predictors did not show any increase in aggregation propensity for this 
mutant. We also found a couple of mutations, which emerged to affect the predicted 
aggregation propensity of CRABP 1. These include mutations I52A and L118V. 
isoleucine 52 is found in strand 3 and leucine 118 is found in strand 9 (Appendix B). 
I52A substitution had a lower overall predicted aggregation propensity resulting from a 
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decrease in CRABP 1 β-propensity and hydrophobicity attributed to the substitution of 
isoleucine to alanine (Appendix C). However, in contrast to predictions, compared to the 
WT protein, I52A mutant was completely insoluble upon overexpression in E. coli (Table 
2.1). In the case of L118V the substitution increased the hydrophobicity of the protein 
thus a higher aggregation propensity was predicted (Appendix D) Experimentally, we 
find L118V is moderately (~50% soluble after 3 hours of protein overexpression) 
aggregation-prone in comparison to WT CRABP 1 (Table 2.1). Examination of 
aggregation propensities of CRABP 1 mutants suggests that effects of single amino acid 
substitutions on globular proteins cannot be sensitively predicted based solely on protein 
sequence. Other factors such as thermodynamic stability and structural fluctuations 
inherent for different proteins, which dictate the exposure of aggregation-prone 
sequences must be integrated in models to forecast aggregation propensities. 
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Table 2.1. Aggregation propensities and thermodynamic stabilities of CRABP 1 
variants 
 
∆∆GU-N (energetic effect of mutations on the free energy of the unfolded state (U) with 
respect to the native state (N)) = ∆GU-N
WT - ∆GU-N
Mutant 
Aggregation propensities were determined based on partitioning of the protein into 
soluble and insoluble fractions after overexpression in E. coli for 3 hours at 37oC. 
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2.2.2. Sequestered sequences in CRABP 1 in vitro and in vivo aggregates 
 
In order to find significance in our experiments, we first explored how aggregation 
in vitro compared in vivo. Thus we performed experiments to compare morphologies and 
molecular interactions stabilizing in vitro and in vivo aggregates. To inspect the 
morphologies of the in vitro and in vivo aggregates, transmission electron microscopy 
(TEM) was performed. Inclusion bodies were purified from washing the cell pellet with 
non-ionic detergent and treating with lysozyme and DNase. To yield in vitro aggregates, 
aggregation-prone F71A CRABP 1 mutant proteins isolated from inclusion bodies were 
refolded from high urea concentrations into buffer without urea at pH 7.0 containing 150 
mM NaCl and 5 mM DTT at 37oC. Insoluble aggregates were formed during refolding of 
aggregation-prone mutants at high concentrations (above 50 µM) under these 
conditions. Aggregates generated under these different conditions appeared amorphous 
and non-fibrillar consistent with previous observations (Ignatova & Gierasch, 2005). 
Although both were amorphous, the morphologies were different. In vivo, CRABP 1 
forms uniform globular aggregates while aggregate formed in vitro did not (Appendix E).  
 
To interrogate whether there are contiguous sequences sequestered in these 
amorphous aggregates and whether they are consistent with predicted aggregation 
hotspots, aggregate cores of both in vitro and in vivo aggregates were mapped. Using 
DMSO-quenched hydrogen deuterium exchange NMR as an approach, aggregation 
cores of in vitro aggregates and inclusion bodies of CRABP 1 mutants were determined. 
15N-labeled in vivo aggregates of F71A mutant were isolated using a non-ionic 
detergent. We estimated the purity of the inclusion bodies to be around 80-90% 
(Appendix F). Previous reports on the quality of purified inclusion bodies revealed that 
although inclusion bodies generally consist of overexpressed recombinant proteins, a 
small fraction of contaminating proteins are present (Ventura & Villaverde, 2006). These 
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include proteolytic fragments of the recombinant protein, molecular chaperones such as 
small heat-shock proteins (IbpA and IbpB), DnaK and GroEL (Ventura & Villaverde, 
2006, Dasari, et al., 2011). Purified CRABP 1 inclusion bodies were tested for the 
presence of molecular chaperones DnaK and small heat shock protein, IbpA by western 
blot. Purified inclusion bodies from several aggregation-prone CRABP 1 mutants did not 
show presence of DnaK but were positive for IbpA (Appendix G).  
 
Isotopically-labeled proteins in inclusion bodies and in in vitro aggregates for 
NMR studies were prepared as previously mentioned. Aggregates were exchanged in 
D2O for four weeks to determine the highly protected cores. Incubation was performed 
for four weeks to ensure exhaustive exchange. Reactions implemented at different time 
intervals showed that no significant exchange occurs after four weeks. Aggregates were 
collected, lyophilized and resuspended in DMSO-d6 containing 0.1% (v/v) trifluoroacetic 
acid (TFA), 50 mM DTT and 5% (v/v) D2O (pD 3.0-3.5) to a final protein concentration of 
200 µM. Quench reactions were done at pD=3.0-3.5 1H-15N HSQC NMR experiments 
were performed to monitor amide protons. We performed our experiments in buffers with 
pD=3.0 to 3.5 instead of pD=5.0, the condition suggested by Hoshino and Goto that 
minimizes back-exchange, since we find less pH-dependent chemical shifts under this 
condition. We performed backbone residue assignments using purified 13C/15N-labeled 
WT* CRABP 1 dissolved in quench buffer. We observed a narrow and crowded 2D 
spectrum with a number of overlapping peaks. Hence, we added another dimension by 
performing several triple-resonance NMR experiments to resolve individual residues. 
Backbone assignments were transferred to the spectra of the mutant protein and 
adjusted accordingly for any shifts associated with the mutations. Figure 2.4 shows a 
typical HSQC spectra of mutant CRABP 1 aggregates dissolved in DMSO. In total 128 
out of 158 amino acid residues (around 80%) have peaks assigned. NMR spectra for 
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both in vitro and in vivo aggregates were compared before and after exchange. For 
controls, the unexchanged samples were incubated in water for the same amount of 
time and quenched under the same conditions as in the exchanged samples. It is worth 
mentioning that aggregates remained stable even after long periods of incubation in 
either water or D2O. We have also performed initial control experiments to monitor back-
exchanges to determine the duration for data acquisition by taking HSQC measurements 
of unexchanged aggregates every hour over a 24-hour period. We found little back-
exchange if measurements were performed within two hours after dissolution of 
aggregates in DMSO. In our experiments, our data acquisitions were completed within 
30 minutes after dissolving the aggregates. 
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Figure 2.4. 1H15N HSQC Spectra of F71A CRABP 1 before and after hydrogen-
deuterium exchange. The NMR spectrum before exchange (left), shows several 
intense peaks with their residue assignments. On the right is the NMR spectrum after 
exchange showing less peaks. These remaining peaks correspond to the aggregation 
cores.  
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A comparison of the acquired HSQC NMR spectra from in vivo and in vitro 
aggregates revealed that in vivo aggregates contained additional peaks not originating 
from CRABP 1 (Figure 2.5). These peaks may be attributed to the presence of 
contaminating proteins in the inclusion bodies. As we have mentioned earlier, we found 
a small percentage of other proteins in our samples. Additional peaks have also been 
observed in HSQC spectra of inclusion bodies from other proteins (Dasari, et al., 2011).  
 
As we expected, both in vitro and in vivo aggregates had only few but strong 
peaks remaining after exchange. Individual residues corresponding to intense peaks 
after exchange were identified. For in vitro aggregates, residues 51-65 with the 
exception of serine 55 (core 1), 119-123 (core 2) and 127-134 (core 3), were extremely 
protected (Figure 2.5). A comparison of aggregation core sequences with predictions 
correlated very well with predicted aggregation hotspots (Figure 2.6). Except for residues 
along the helical domain, we were able to observe high solvent protections in β-strands 
predicted by the different algorithms. Core 1 is located in the strand 3, turn II, and strand 
4 while cores 3 and 4 are situated in strands 9 and 10 respectively (Figure 2.7). 
Surprisingly the exact same regions of CRABP 1 were found for the in vivo aggregates. 
Backbone amides of residues 52-64, 120-123 and 127-134 remain protonated.  
 
To check whether the same sequences form the aggregation cores for other 
mutants, hydrogen exchange NMR experiments were also performed on L118V and 
I52A CRABP 1 inclusion bodies. All mutants contained highly protected residues and 
were consistent with those identified for F71A mutant (Figures 2.5). It is interesting that 
although both mutants are found close to two different aggregation cores, there was no 
preference for aggregation cores close to the mutation. 
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Figure 2.5. HSQC spectra of CRABP 1 inclusion bodies before and after hydrogen 
exchange. Inclusion bodies from moderately aggregation-prone mutant L118V (left) and 
highly aggregation-prone mutants F71A and I52A (center and right) were allowed to 
exchange in D2O containing 0.025% NaN3 for four weeks. Inclusion bodies were 
dissolved in DMSO-d6 containing 0.1% TFA and 5 mM DTT. Mutants of CRABP 1 
contain similar aggregation core segments as revealed by similar peaks remaining after 
exchange. 
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Figure 2.6. Experimentally determined and predicted aggregation-prone regions  
of CRABP 1. Aggregation cores of CRABP 1 determined by hydrogen exchange 
mapped against the amino acid sequence. Also aligned with the sequences are the 
predicted aggregation segments. These cores were consistent to predictions 
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Figure 2.7. Aggregation cores of CRABP 1. 
Aggregation-prone segments mapped on the structure of CRABP 1 (orange highlights). 
Aggregation cores are found at strands 3, 4, 9 and 10 and in turn 2 of CRABP 1. 
Indicated in the structure are the locations of the mutations: Phe71 (blue); Ile52 (red) 
and Leu118 (green). 
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To verify whether the very slow exchange behavior of the aggregation cores is 
distinct from the other residues, residual peak intensities from triple resonance HNCO 
experiments were compared at different time points. In order to minimize acquisition 
time, sparse HNCO experiments (Orekhov, et al., 2003, Jaravine, et al., 2008). Sparse 
3D experiments applies non-Fourier transform methods for analysis and non-uniform 
sampling to minimize data acquisition time while maintaining good resolution. HNCO 
experiments were performed on I52A CRABP 1 inclusion bodies exchanged at varying 
time intervals. Intensities of individual, non-overlapping peaks were determined and 
plotted with time (Figure 2.8). We did not extract thermodynamic parameters from our 
quantitation since the peak intensities had low signal to noise ratios. However, we were 
able to classify residues based on two types of behaviors; fast and slow exchanging 
residues. In fast exchanging residues, we observed a rapid decrease in intensity within a 
few hours of exchange and after two weeks, signals have deceased at least five-fold 
(Figure 2.8). However, for slow exchanging residues, signal intensities decrease slower 
and still contain at least 30% of their intensities after two weeks of exchange. 
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Figure 2.8. HNCO peak intensities of CRABP 1 residues from aggregates 
exchanged over time 
 
A) Peak intensities obtained from sparse HNCO spectra (each spectra were recorded for 
less than 2 hours to minimize H/D exchange during experiments of highly aggregation-
prone CRABP1 mutant I52A aggregates in 95% d6-DMSO/5% D2O for the 
unexchanged sample (red) and samples that were H/D-exchanged (yellow) for 6 hours 
(top) and 2 weeks (bottom). All assigned residues those peaks have signal-to-noise ratio 
more than 10 (and errors in peak intensities more than 10%) for the unexchanged 
sample were used for analysis. Resonances for residues from the aggregation core(s) 
(middle and right) retained significant (30-60% from intensities for the unexchanged 
sample) intensities after 2 weeks of exchange, while intensities for the rest resonances 
(with exception of Phe3) decreases in more than 5 times (left).  
 
B) Relative peak intensities as a function of H/D-exchange time, I(exch)/Io×100%, where 
I(exch) and Io are peak intensities for residues shown on (A) [with exception of Phe3, the 
quality of data for this residue is too noisy for analysis] obtained from H/D-exchanged 
and unexchanged samples, respectively. Residues from the aggregation cores (shown 
in blue) have a significantly slower decay for relative peak intensities as comparing with 
the rest protein (red); while behavior of the (different) aggregation core(s) are similar 
within experimental errors (10-20%).  
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2.3. Discussion 
2.3.1. Common Sequences Direct Aggregation of CRABP 1  
Protein folding and aggregation are driven by similar amino acid properties such 
as hydrophobicity, secondary structure propensity and charge. Thus, competition 
between intramolecular and intermolecular interactions, which direct folding and 
aggregation respectively, is inevitable. However, the balance between folding and 
aggregation can be shifted under defined conditions allowing a plethora of independent 
mechanistic studies. This study aims to make a connection between folding and 
aggregation to provide a comprehensive picture that will illustrate the fate of a 
polypeptide chain. Here, sequence determinants that link folding and aggregation of a β-
protein were described. In addition, we demonstrated the specificity of aggregation by 
comparing aggregate structures of various mutants generated in vitro and in vivo.  
 
CRABP 1, a β-clam protein whose folding mechanism has been studied in detail 
was used as a model. Owing to their rugged folding energy landscapes with high degree 
of frustration, multiple intermediate states and increased propensity to aggregate, 
predominantly β-sheet proteins are an apt structural class for examining molecular 
details of the balance between folding and aggregation. CRABP 1 folds via two 
intermediate states an early collapsed state (I1) and a later β-molten globule-like state 
with native topology (I2) – and thus exemplifies β-barrel frustration (Clark, et al., 1996, 
Clark, et al., 1997, Clark, et al., 1998). Despite this, CRABP 1 and members of its class 
fold and avoid aggregation efficiently. To study how CRABP 1 protects itself from 
aggregation, we mapped sequences that are sequestered in aggregates. As we discover 
the role of these sequences in folding of CRABP 1 from previous studies we were able 
to find clear links to aggregation. 
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First we interrogated whether aggregation is specific by comparing the molecular 
characteristics of in vitro and in vivo aggregates of CRABP 1. We initially developed 
protocols to generate in vitro and in vivo aggregates. For in vitro aggregates we aimed to 
produce aggregates that will simulate how proteins aggregate in cells but in the absence 
of other complexities such as a crowded environment and other cellular machineries 
such as molecular chaperones and proteases. An aggregation-prone mutant F71A was 
overexpressed as inclusion bodies and purified in high urea. With the protein denatured 
in urea, it mimics an unfolded nascent chain. From a highly denaturing environment, the 
protein was refolded into native-like buffer conditions. During this process, depending on 
the initial protein concentration, a significant amount of aggregates are formed permitting 
us to analyze its structure. To generated in vivo aggregates, the mutant protein was 
overexpressed as inclusion bodies and purified using a mild non-ionic detergent. Using 
this method, cell lysis was efficient yet inclusion bodies remained intact. As mentioned in 
the previous section, several other proteins co-aggregated with CRABP 1. We have 
noted the presence of small heat shock protein IbpA. Small heat shock proteins IbpA 
and IbpB bind to aggregated proteins and change their physical properties to mediate 
disaggregation and refolding by chaperones (Ratajczak, et al., 2009). Aggregates 
derived in vitro and in vivo were strikingly different in morphologies. In vitro aggregates 
appeared heterogeneous with no distinct shape while inclusion bodies had the typically 
observed round shaped structures (Ignatova & Gierasch, 2005, Morell, et al., 2008). It 
appears that in a crowded cellular environment, aggregation of proteins is confined in 
space giving rise to compact inclusions. An interesting aspect to further explore is the 
potential role of bound small heat shock proteins in modulating aggregate morphologies 
and molecular structures in cells.  
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To characterize the interactions that stabilize aggregates, DMSO-quenched 
hydrogen exchange was performed and monitored using solution NMR. The use of this 
protocol allowed us to resolve regions of protein sequestered from the solvent in 
aggregates. DMSO dissolved in vitro aggregates almost instantly while inclusion bodies 
were only partly soluble. A small percent of the inclusion bodies, which may be non-
protein components, was insoluble in DMSO. However, these did not interfere with the 
analysis. Dissolution of aggregates in DMSO provided high sensitivity allowing us to 
study consecutive regions of CRABP 1 extremely resistant to solvent exchange by NMR. 
Analysis of the aggregates derived under extremely diverse conditions revealed 
common sequence motifs that drive aggregation. These sequences correlated to a high 
extent with that of predicted aggregation hotspots. These suggests that the physico-
chemical properties of protein sequences as evaluated by several aggregation predictors 
dictate the potential to be sequestered in aggregates. The identical sequences in 
aggregation cores in vitro and in vivo supports the idea that although aggregation 
involves interaction between hydrophobic patches it is specific even under extremely 
variant conditions. In separate reports, it has been shown that inclusion bodies, although 
amorphous, have high specificity similar to highly ordered amyloid structures (de Groot, 
et al., 2008, Morell, et al., 2008, Wang, et al., 2008). Thus inclusion bodies have been 
proposed to be useful models for intermediates in amyloid formation (Dasari, et al., 
2011).  
 
To further investigate whether other aggregation-prone mutants contain the same 
core structures, L118V and I52A CRABP 1 mutants were also tested. L118V has a high 
predicted and moderate experimental aggregation propensity. However, I52A has a 
lower predicted aggregation propensity but was highly aggregation-prone. Leu118 is 
close to aggregation core 2 and Ile52 is in core 1 based on the core sequences identified 
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on F71A CRABP 1 mutant. Using the same hydrogen exchange method, the 
aggregation cores determined in these mutants corresponded to the same amino acid 
stretches determined for F71A mutant. These suggest that the population of common 
aggregation-prone intermediate/s that expose the same consensus sequences dictates 
the extent of aggregation of CRABP 1. In the following chapter, we will describe 
experiments performed to resolve the aggregation-prone intermediate of CRABP 1 
under native conditions. 
 
2.3.2. Common Sequence Motifs Drive Aggregation and Folding of CRABP 1  
An extensive study on the early events in folding of CRABP 1 was done in 
parallel with this study (Budyak, et al., 2013). In this study single residue substitutions at 
33 sites were introduced in the CRABP 1 sequence with comprehensive coverage of 
structural elements including the minor hydrophobic core near the barrel closure region 
(Budyak, et al., 2013). The observed impact of these mutations on CRABP 1 stability 
and unfolding kinetics revealed that its rate-determining transition state (TS) is highly 
polarized (Budyak, et al., 2013). It showed that the barrel closure interactions formed 
before the TS, and interactions in the major hydrophobic core developing only after the 
TS (Budyak, et al., 2013). Barrel closure of CRABP 1 involves partner interactions 
between strand 10 and strand 1. It is speculated that the early docking and specific 
interactions between these terminal strands help simultaneously assemble the front and 
back sheets of the barrel assisting the rapid folding of CRABP 1 (Budyak, et al., 2013).  
 
Consistent with the results on the folding studies, strand 10 was invariably 
predicted to be an aggregation hotspot. Experimentally, we have also resolved these 
regions of the proteins to be sequestered in the cores of aggregates. Strand 10 is a 
typical edge strand, an interface that can transiently be exposed leading to aggregation 
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(Richardson & Richardson, 2002, Soldi, et al., 2008, Chiti & Dobson, 2009). Early barrel 
closure in the folding mechanism of CRABP 1 would protect strand 10 by providing a set 
of partner interactions, thus mitigating its vulnerability as an unpartnered edge strand 
(Budyak, et al., 2013). The aggregation core 2, involving strand 9 is also intrinsically 
labile (Krishnan, et al., 2000, Xiao & Kaltashov, 2005) also becomes protected upon 
closure of the barrel. Thus, taken together, it is hypothesized that protection of 
aggregation-prone regions in CRABP 1 by structural features and barrel closure occurs 
early in folding and significantly reduces its risk of aggregation. Our findings on a 
common sequence motif in CRABP 1 that initiate folding and aggregation demonstrate a 
clear connection between the two processes involving very distinct interactions. It is 
argued in this case that folding involves protective mechanisms that may have evolved 
to prevent aggregation. However, we also show that there is a very delicate balance that 
can be shifted in either direction. The following chapter will demonstrate how despite 
several protective mechanisms, local fluctuations in the native state can trigger 
aggregation. 
 
2.4. Experimental Procedures 
Cell partitioning experiments 
Variants of CRABP 1 were overexpressed until OD600=0.8 and protein expression 
were induced for three hours at 37oC. Cells were lysed using bacterial protein extraction 
reagent BPER II (Thermo Scientific) following manufacturer’s protocol. Lysates were 
spun down at 20,000 for five minutes. After centrifugation, soluble and pellet fractions 
were separated. Pellet fractions were dissolved 8M urea using equal volumes with the 
soluble fractions. Soluble fraction and dissolved pellet were mixed SDS-loading dye and 
boiled for five minutes then run on 12% Tricine SDS-PAGE. Protein bands were stained 
with Coomassie blue and observed using a GelDoc system (Biorad). Distributions of 
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CRABP 1 mutant proteins in each fraction were determined by taking the ratio of the 
optical density of the band corresponding to CRABP 1 in both pellet and soluble 
fractions with respect to the lysate fraction. 
 
Expression and purification of proteins from inclusion bodies 
CRABP 1 mutants were generated using a stabilized variant of murine CRABP 1 
(WT* CRABP 1) (Clark, et al., 1998) and N-terminal (His)10-tag as background template 
incorporated into a PET16b vector. Single residue substitutions were introduced into the 
WT* CRABP 1 sequence by site-directed mutagenesis using a QuikChange protocol 
(Stratagene). The WT* and mutant proteins were expressed in BL21(DE3) E. coli strain 
(Novagen) either in Luria-Bertani media (non-isotopically labeled proteins) or M9 
minimum media containing 15NH4Cl and/or 
13C-glucose (for isotopically labeled proteins). 
E. coli cells containing plasmids for WT* CRABP 1 were grown until OD600=0.7-0.8 and 
protein expression was induced using 0.4mM IPTG for four hours at 30oC. To produce 
CRABP 1 mutants as inclusion bodies, cells were grown at OD600=0.8-1.0 and 
overexpressed at 37oC for four hours for non-isotopically labeled proteins and six hours 
for isotopically labeled proteins. Cells were resuspended in lysis buffer  (50 mM sodium 
phosphate, pH 8.0, 300 mM NaCl) and disrupted using Microfluidizer M-110L processor 
(Microfluidics). To purify soluble WT* CRABP 1, we collected the supernatant and ran on 
a Ni-NTA agarose affinity column (Qiagen) at over an increasing imidazole gradient. 
Fractions containing pure proteins were dialyzed in 10 mM ammonium bicarbonate and 
lyophilized overnight. For proteins isolated from inclusion bodies, pellet fractions were 
collected and resuspended in lysis buffer containing 8M urea. Protein solutions were 
eluted on a Ni-NTA affinity chromatography column at room temperature using buffers 
containing 8M urea with increasing imidazole concentrations. Absorbance at 280 nm 
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was taken to determine the concentration of purified proteins and using the extinction 
coefficient 21,294 M-1 cm-1.  
 
Preparation of in vitro aggregates 
To generate in vitro aggregates, fractions containing purified F71A CRABP 1 
mutant in urea were dialyzed in 10 mM phosphate buffer pH 7.0 containing 150 mM 
NaCl and 5 mM DTT at 37oC. Aggregates were collected from the dialysate by 
centrifugation. To determine the concentration of proteins in aggregates, aggregates 
were dissolved in 8M urea and concentrations were determined by taking the 
absorbance at 280nm.  
 
Purification of bacterial inclusion bodies 
Inclusion bodies for these aggregation-prone mutant proteins were purified using 
a non-ionic detergent, BPER II combined with lysozyme treatment. Purification of 
inclusion bodies was performed following manufacturer’s instructions with slight 
variations. The following procedures to purify inclusion bodies were performed in small 
aliquots (15mL cell culture) for efficient separation of contaminants. Cells were collected 
after centrifugation at 4,000 rpm for 10 min and resuspended in BPER II bacterial protein 
extraction reagent (Thermo Scientific) at 1:10 (BPER II: bacterial growth culture) ratio. 
The cell suspension was vortexed and centrifuged to collect the pellet. The pellet was 
resuspended in the same volume of BPER II and treated with lysozyme (0.4mg/mL). 
Pellet was washed with twenty-fold diluted BPER reagent. Wash steps were repeated 
trice. Pellet was washed with 10 mM Tris-HCl pH 8.0 and then with distilled deionized 
water. To check the purity of the inclusion bodies, these were resuspended in 8M urea 
and ran on a 12% SDS-PAGE. In order to check the concentration of CRABP 1 mutants 
in the aggregates, inclusion bodies were ran on an SDS-PAGE along with protein 
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standards of known concentrations. Band intensities of standard proteins were taken to 
generate a standard curve and from this, the concentrations of inclusion bodies were 
determined. 
 
Hydrogen exchange NMR of aggregates 
We identified the aggregation core residues of CRABP 1 inclusion bodies using 
hydrogen-deuterium (H/D) exchange and monitored by solution NMR spectroscopy as 
described previously (Hoshino, et al., 2002). Briefly, 15N/13C-labeled CRABP 1 inclusion 
bodies of F71A, L118V and I52A CRABP 1 mutants were incubated in D2O for four 
weeks at 4 °C. Aggregates were collected, lyophilized and then resuspended in d6-
DMSO containing 0.1% (v/v) TFA, 50 mM DTT and 5% (v/v) D2O (pD 3.0-3.5) to a final 
protein concentration of at least 200 µM. The solution was immediately transferred to an 
NMR tube, and the heteronuclear single quantum coherence (HSQC) spectrum was 
recorded at 26 °C on a 600-MHz Bruker Avance spectrometer using a TXI cryoprobe. 
For unexchanged samples, inclusion bodies were resuspended in water containing 
0.025% (w/v) NaN3 and incubated at 4°C for four week. NMR data were processed using 
NMRPipe (Delaglio, et al., 1995). Backbone assignments of CRABP 1 aggregates 
dissolved in DMSO were obtained using a standard set of triple resonance experiments, 
including HNCACB, CBCA(CO)NH, HBHANH, HNCO, and HNCACO. 
 
Sparse 3D HNCO experiments were performed on DMSO dissolved inclusion 
bodies initially incubated in D2O at different time points, using a 700-MHz NMR Varian 
spectrometer. Relative peak intensities as a function of H/D-exchange time, 
I(exch)/Io×100%, where I(exch) and Io are peak intensities for assigned residues were 
determined.  
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CHAPTER 3 
PROTEIN AGGREGATION: BALANCE BETWEEN INHERENT DYNAMICS AND 
FUNCTIONAL INTERACTIONS OF A β-PROTEIN 
 
This chapter describes results of collaborations with Anastasia Zhuravleva, Ivan Budyak 
and Lila Gierasch 
 
3.1. Introduction 
In order to function proteins have evolved to correctly self-assemble into their 
three-dimensional native fold. In a protein’s energy landscape it is inevitable that the 
multiple intermediate species populated prior to the native state may tip the balance 
between folding and aggregation (Brockwell & Radford, 2007, Jahn & Radford, 2008). In 
addition to this complexity, local fluctuations driving partial exposure of hydrophobic 
stretches in the native state may precede aggregation (Bemporad, et al., 2012, 
Neudecker, et al., 2012, Sabate, et al., 2012). Recently, it has been proposed that 
functional interactions rather than folding primarily compete with aggregation (Masino, et 
al., 2011, Pastore & Temussi, 2012). Over the past years, mechanisms of aggregation 
have been studied on a few small globular proteins but no clear link between folding, 
function and aggregation has been elucidated (Booth, et al., 1997, Villanueva, et al., 
2004, Yamaguchi, et al., 2004, Hamada, et al., 2009, Pagano, et al., 2010). It remains 
very confounding how a protein is fine-tuned to favor protein stability and necessity to 
function over aggregation. In this chapter, we interrogate the following: How does a 
natively folded protein become susceptible to aggregation? How do functional 
interactions counteract the risk of aggregation? What intrinsic and extrinsic protective 
mechanisms help attenuate aggregation? 
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These questions were addressed using our model protein CRABP 1 to examine 
the complex balance between folding, aggregation and functional interactions. As 
discussed in Chapter 2, CRABP 1 possesses a robust folding mechanism that protects it 
from aggregation. However, the remaining question is how despite protective 
mechanisms, CRABP 1 is drawn to aggregate. WT* CRABP 1 under native-like 
conditions in vitro, aggregates to a minimal extent. However, this propensity is further 
aggravated by addition of small amounts of denaturant or introduction of single residue 
substitutions that do not affect the protein’s overall stability. In this chapter an 
aggregation-prone intermediate populated under near native conditions was identified. 
Using several biophysical tests, we show that the inherent “breathing” of CRABP 1 
exposes the highly aggregation-prone segments identified in Chapter 2. This dynamic 
motion is associated with the innate movement of the helical domain away from the β-
barrel body and the loosening of interactions in the ligand portal region. However, 
previous studies show that interaction with the ligand halts this motion and stabilizes the 
complex (Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Here we will demonstrate 
inhibition of aggregation by retinoic acid suggests the role of ligand interactions in 
offsetting aggregation. Our findings on the aggregation of CRABP 1 demonstrate the 
complex intimate overlap between folding, functional roles and aggregation of proteins.  
 
3.1.1. Native State Dynamics and Aggregation Propensity 
In this section, we will recollect how the behavior of native proteins are currently 
viewed and from here highlight circumstances that endanger native proteins towards 
aggregation. By looking at crystal structures one might picture folded proteins as having 
rigidly fixed conformations. But in reality, protein fluctuations around the native structure 
may be attributed to its function to either form interactions with other proteins or binding 
specific ligands. Descriptions of how proteins form specific interactions have developed 
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through the years. The classical mechanism of a “lock and key” model initially proposed 
by Emil Fischer where an enzyme interacts with its substrate via exact geometric 
complementarity has evolved into a more mechanistically dynamic interaction referred to 
as the “induced fit” model (Koshland, 1958, Csermely, et al., 2010). In the induced fit 
model, binding events between a protein and a rigid ligand promotes conformational 
changes (Koshland, 1958). However, more recently it has been proposed that the native 
state is not only one distinct conformation but an ensemble of states for which protein 
binding follows a “conformational selection” process. This paradigm suggests that 
proteins fluctuate forming a conformational ensemble and a ligand selects one form 
compatible to binding and shifts the equilibrium towards this state (Csermely, et al., 
2010). This is described as “conformational selection and population shift phenomena”. 
In Chapter 1 native state ensembles have been described through multiple shallow wells 
in the energy landscape. The heights of energy barriers associated with protein motions 
can be described based on their timescales (Henzler-Wildman & Kern, 2007) (Figure 
3.1). Fast protein dynamics involves local flexibility through bond vibrations, methyl 
rotations, loop motions and side-chain rotamers, which are in femtoseconds to 
nanoseconds timescales (Henzler-Wildman & Kern, 2007). Slow protein dynamics are in 
the microseconds to millisecond timescales demonstrated by large domain movements 
and collective motions (Henzler-Wildman & Kern, 2007). The rapid fluctuations have 
very low energy barriers compared to slower motions (Henzler-Wildman & Kern, 2007). 
Of the two types of dynamics, ensembles in slow timescales are more relevant to protein 
functions. 
 
 Selection for functional conformations of proteins have already been described 
experimentally (Csermely, et al., 2010). Nevertheless, although the initial steps for ligand 
recognition of conformational selection and induced fit paradigms are different, the 
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distinction is not very clear since several interactions appear to require both. The model 
was then further refined into an “extended conformational selection” process (Wlodarski 
& Zagrovic, 2009). This extension describes that the binding process not only changes 
the energies of the interacting partners but also alters the shape of the entire energy 
landscape (Csermely, et al., 2010). This was clearly illustrated in an NMR study on 
structural ensembles of ubiquitin during binding revealing equal contributions from both 
conformational selection and conformational rearrangements (Wlodarski & Zagrovic, 
2009). The ability of proteins to form interactions by sampling several conformations 
implies the possibility of visiting a high-energy poorly populated state prone to form 
undesired self-interaction (Neudecker, et al., 2012). In the following section, we will show 
a few examples of proteins that demonstrate the progressive view of an interconnection 
between function and aggregation.  
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Figure 3.1. One-dimensional cross-section through the high-dimensional energy 
landscape of a protein showing the hierarchy of protein dynamics and the energy 
barriers. ∆G
± corresponds to the free energy barrier between the populated states. Tiers 
are divided according to the timescales of protein motions. Tier 0 represents slow 
dynamics associated with large domain motions important for protein functions. 
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3.1.2. Linkage between Functional Interactions and Aggregation 
In Chapter 1 we have mentioned several proteins that aggregate under 
physiological conditions suggesting a connection between functional dynamics and 
aggregation. From the view of conformational selection, aggregation may be an outcome 
of high energy less populated states of the native state ensemble (Csermely, et al., 2010, 
Neudecker, et al., 2012). A systematic study conducted on protein-protein complexes 
from structures deposited in the Protein Data Bank (PDB) showed evidence on shared 
physicochemical properties between functional interfaces and aggregation-prone regions 
(Pechmann, et al., 2009). In this study, the interface regions correlated with aggregation 
hotspots projected on protein surfaces (surface aggregation propensity) of homodimers, 
heterodimers and homotrimers (Pechmann, et al., 2009). In all cases, hydrophobic 
interactions were the best indicator for functional and aberrant protein-protein 
associations (Pechmann, et al., 2009). There have been a small number of studies 
directly showing functional interfaces in proteins forming aggregates. We will briefly 
discuss these few examples, which include the cases of ataxin-3, p53, β-lactoglobulin 
and SUMO proteins. 
 
3.1.2.1. Ataxin-3  
Ataxin-3 (atx3) is a conserved and ubiquitously expressed enzyme whose 
function is not yet clearly understood (Matos, et al., 2011). However, there have been 
several evidence pointing to its important role in protein turnover by the Ubiquitin-
Proteasome Pathway because of its ability to recognize polyubiquitin chains and polyUb-
editing proteolytic activity. Atx3 interacts with a number of proteins involved in protein 
homeostasis maintenance, transcription regulation, cytoskeleton organization and 
myogenesis. The structure of ataxin-3 is composed of a structured globular N-terminal 
domain referred to as Josephin domain (JD), which is responsible for the protease 
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activity followed by a flexible C-terminal tail consisting of ubiquitin binding motifs and a 
polyglutamine (polyQ) region. Increased length of the polyQ expansion has been 
associated with neurodegeneration called Machado-Joseph disease (MJD), the most 
common form of spinocerebellar ataxia. Atx3 presents as inclusions in neurons and 
axons in brains of patients suffering from MJD. In addition, quality control proteins 
including ubiquitin and molecular chaperones co-aggregate with atx3 in diseased brains. 
It has been shown that in the absence of the polyQ tail, atx3 aggregates under native 
conditions (Gales, et al., 2005). It is shown that the folded Josephin domain modulates 
the stability and regulates self-association (Masino, et al., 2004). Under these native 
conditions, Josephin domain nucleates atx3 fibrillation suggesting it role in the early 
stages of aggregation (Masino, et al., 2004, Gales, et al., 2005). A detailed study to 
identify aggregation-prone regions of Josephin domain uncovered two solvent exposed 
patches (Masino, et al., 2011). These solvent exposed interfaces have been identified to 
be important in ubiquitin binding (Masino, Nicastro et al. 2011). To further demonstrate 
competition between self-association and functional interactions, they showed that 
addition of ubiquitin slowed down aggregation and changed the morphology of 
aggregates (Masino, Nicastro et al. 2011). 
 
3.1.2.2. p53 protein 
p53 is a tumor suppressor protein that is central to an extremely complicated 
cellular signaling network. p53 mediates a wide range of responses by recognizing 
signals for oncogene activation, DNA damage and oxidative stress and to initiate repair 
mechanisms, cell cycle arrest or apoptosis (Aylon & Oren, 2007). Approximately half of 
known cancers have mutations in the p53 gene. Majority of these cancers have 
impairment in the positive and negative transcriptional regulation of function of p53. p53 
is active as a tetramer. The N-terminus consists of disordered transactivation domain 
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(TAD) and a proline-rich region (Joerger & Fersht, 2008). The central region consists of 
a folded DNA-binding core domain linked to a tetramerization domain (Joerger & Fersht, 
2008). At the C-terminus of p53 is a disordered basic regulatory domain which binds 
DNA non-specifically (Joerger & Fersht, 2008). Post-transcriptional modification of the 
p53 by phosphorylation, acetylation, methylation and modifications with ubiquitin-like 
proteins affects its function and stability (Vousden & Lane, 2007). Aside from the effects 
of mutations in p53 for its multiple functions, p53 is also shown to aggregate. Large 
aggregates of wild-type p53 protein have been observed in the cytoplasm and nucleus of 
neuroblastomas, carcinomas and myelomas (Moll, et al., 1996, Ostermeyer, et al., 
1996). Succeeding experiments to reveal the nature of the aggregates revealed the 
tendency of its functional domains to self-associate. The central DNA binding domain, 
the tetramerization domain and the disordered TAD have all been found to be involved in 
the cores of aggregates (Ishimaru, et al., 2003, Higashimoto, et al., 2006, Rigacci, et al., 
2008). It has been reported that kinetic partitioning between folded and misfolded 
proteins lead to a decrease in DNA binding for p53. Consistent with a common DNA 
binding interface and aggregation cores, interaction of p53 with a consensus DNA 
sequence inhibits aggregation.  
 
3.1.2.3. β-lactoglobulin 
β-lactoglobulin is a non-obligate homodimeric, β-barrel protein consisting of eight 
anti-parallel strands (A-H) with an extra stand, I, which is involved in dimerization and a 
helix at the C-terminal end. At low pH, the dimer dissociates into folded monomers 
(Uhrinova, et al., 2000, Hamada & Dobson, 2002). β-lactoglobulin is a member of the 
lipocalin family and has a large structural plasticity (Gutierrez-Magdaleno, et al., 2013). 
Its large hydrophobic cavity enables it to bind to diverse hydrophobic ligands (Gutierrez-
Magdaleno, et al., 2013). Based on calorimetric studies, ligand binding promotes dimer 
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dissociation (Gutierrez-Magdaleno, et al., 2013). The protein also contains two disulfide 
bonds which links strands D and I and G and H. Under denaturing conditions, β-
lactoglobulin forms aggregates but only after prolonged incubation. However, 
aggregation can be triggered by reduction of disulfide bonds. Under oxidizing 
environments, strand I is stabilized by disulfide bonds and favors dimerization. However, 
under reducing conditions, strand I frays away from the β-barrel and leading to 
aggregation (Hamada, et al., 2009). β-lactoglobulin exhibits another case where 
functional dimerization interfaces coincide with aggregation-prone regions. In addition, 
the ability of ligand binding to compete with dimerization may also provide some hint on 
the possible role of natural ligands in preventing aggregation. 
 
3.1.2.4. SUMO Proteins 
Small ubiquitin-related modifier (SUMO) proteins are highly conserved proteins 
covalently bound to target proteins. Unlike ubiquitin, SUMO proteins do not target 
proteins to degradation rather they modulate protein-protein interactions. SUMO post-
translationally attaches to proteins via a isopeptide bond and participate in transcriptional 
regulation, nuclear transport, maintenance of genome integrity, and signal transduction 
(Johnson, 2004). The downstream effect of sumoylation varies for every substrate. 
SUMO can either promote complex formation of substrates but can also prevent 
interactions such as blocking ubiquitination. Similar to ubiquitin, SUMO proteins have a 
ββαββαβ fold. The two C-terminal Gly residues required for isopeptide bond formation is 
conserved between ubiquitin and SUMO. SUMO-1 contains a long and flexible N 
terminus, which projecting from the core of the protein not found in ubiquitin. There are 
four isoforms of SUMO (1 to 4). SUMO 2 and 3 are highly homologous. SUMO 
conjugation has been found to increase the solubility of proteins leading to exploration of 
its possible role in regulating aggregation-prone proteins (Krumova, et al., 2011). In 
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addition, SUMO proteins have been popularly used as solubility tags for recombinant 
protein expression (Wang, et al., 2010, Peroutka Iii, et al., 2011). However, despite the 
very high stability of SUMO proteins, slight perturbation of this protein leads to 
aggregation. Detailed analysis of the aggregate structure of SUMO proteins reveals that 
strand 2, is both involved in the binding interface with its substrates as well as in the 
aggregation cores (Sabate, et al., 2012). Furthermore regions of SUMO that have high 
aggregation propensities are also found in its functional interface (Sabate, et al., 2012). 
Aggregation of SUMO provides direct evidence that the need for productive interactions 
also provides risks towards dysfunctional interactions. 
 
3.1.3. Protective Intrinsic Mechanisms From Aggregation 
Although surfaces important for functional and dysfunctional interactions are the 
same, proteins have been designed to prevent aggregation. Proteins have evolved 
utilizing several intrinsic strategies to disfavor aggregation. Even during aggregation at 
physiological conditions, the nature of energy barriers in the native state prevents the 
population of aggregation-prone species (De Simone, et al., 2011). It is through these 
barriers that are dictated by the amino acid sequence by which proteins remain soluble 
in vitro or in cells (De Simone, et al., 2011). Here we will discuss concrete specific 
interactions that create energy barriers to disfavor proteins form populating the 
aggregation-prone state. These include presence of charged residues close to interfaces 
and/or specific interactions involving disulfide linkages and salt bridges (Pechmann, et 
al., 2009).  
 
3.1.3.1. Charges and Aggregation Gatekeepers in Preventing Aggregation 
Charged residues specify binding by either opposing or promoting interactions 
thus playing a role in favoring functional protein-protein interactions over aggregation. 
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(Vendruscolo & Dobson, 2007, Zhang, et al., 2011). Analysis of regions around protein-
protein interfaces revealed charged residues in proximity to these hydrophobic patches 
(Pechmann, et al., 2009). Interface rims formed by the residues that bury <25 Å2 upon 
binding are mostly composed of charged amino acids (Pechmann, et al., 2009). The 
importance of charges on the solubility and binding of proteins has been emphasized in 
a study of a charge-depleted S6 ribosomal protein (Kurnik, et al., 2012). The absence of 
charges did not affect native interactions but triggered aggregation (Kurnik, et al., 2012). 
The presence of charged amino acids commonly found close to aggregation-prone 
regions also referred as aggregation “gatekeepers” inhibit aggregation (Rousseau, et al., 
2006). The existence of these structural gatekeeper residues flanking highly aggregating 
segments suggests selective pressure against aggregation (Rousseau, et al., 2006, 
Beerten, et al., 2012). Obstruction of interactions between aggregation-prone sequences 
is achieved in several ways: 1) repulsive effect of the charged side chains (arginine, 
lysine, aspartate, glutamate; 2) the entropic penalty on aggregate formation by large side 
chains such as arginine and lysine and 3) incompatibility of residues with the β-
aggregate structure as in the case of proline residues (Reumers, et al., 2009). It has 
been reported that mutation of gatekeeper residues result in a number of misfolding 
diseases and other aggregation unrelated diseases such as van der Woude syndrome 
(VWS), Fabry disease (FD), and limb-girdle muscular dystrophy (Reumers, et al., 2009). 
In addition, aggregation-prone segments of critical proteins are the most gate-kept 
(Reumers, et al., 2009). Intrinsically disordered proteins (IDPs) have also been shown to 
flank aggregation-prone sequences (Abeln & Frenkel, 2008). IDPs are natively unfolded 
proteins consisting of only few hydrophobic residues, more hydrophilic and charged 
amino acids and plenty of repeats in their sequence (Rezaei-Ghaleh, et al., 2012). IDPs 
have been proposed obstruct or sterically hinder interactions between aggregation-prone 
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regions (Abeln & Frenkel, 2008). In addition to their safeguarding properties electrostatic 
patches also facilitate chaperone interactions for proper folding (Rousseau, et al., 2006, 
Lawrence, et al., 2007, Kurnik, et al., 2012).  
 
3.1.3.2. Specific Interactions and Structural Adaptations to Prevent Aggregation 
Largely hydrophobic regions in globular proteins are deeply buried in the core of 
proteins to prevent aggregation. Specific interactions ensure that exposure of these 
segments are avoided. Disulfide bonds and salt bridges stabilizing native interactions 
are preferentially found in proximity to interfaces in protein-protein complexes 
(Pechmann, Levy et al. 2009). In the case of β-lactoglobulin, reduction of disulfide bonds 
lead to aggregation (Hamada, et al., 2009). In β-lactoglobulin, the strand involved in 
dimerization is an edge strand. An edge strand is defined as a β-strand found at the end 
of β-sheets or β-sandwiches, that are inherently aggregation-prone by readily forming 
intermolecular H-bonding with a neighboring β-strand (Richardson & Richardson, 2002). 
Edge strands are commonly exposed in proteins that natively form β hydrogen bonds to 
form dimers or oligomers strands (Richardson & Richardson, 2002). In β-lactoglobulin, 
the edge strand is structurally restrained by the presence of disulfide bonds (Hamada, 
Tanaka et al. 2009). In a survey by Richardson and Richardson in 2002 of β-rich 
proteins they identified several “negative designs” or structural adaptation strategies to 
prevent aggregation. A number of specific interactions are employed by β-proteins to 
screen unwanted edge strand interactions. β-barrels prevent edges through continuous 
H-bonding around the barrel cylinder. Parallel β-helices protect β-sheet ends by 
interaction with flexible loops. β-propeller, β-sandwich and single-sheet proteins combine 
β-bulges, prolines, addition of charged side chains in the middle of the strand, shortened 
edge strands and coverage by loop structures to protect edge strands (Richardson & 
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Richardson, 2002). Free edges also contain bends and twists as protective mechanisms 
strands (Richardson & Richardson, 2002).  
 
3.1.3.3. Cellular Strategies to Favor Functional Interactions and Folding over  
Aggregation 
 
Although there have been several examples showing that protein aggregation 
can be beneficial, it is generally a deleterious outcome in cells. However despite the 
negative implications of aggregation, evolution has not successfully eliminated 
aggregation-prone segments in proteins. This can be attributed to their important roles in 
forming compact folded structures as well as in facilitating functional interactions. As 
discussed in the previous section, proteins bear gatekeeping sequences and form 
specific interactions to disfavor aggregation. However, these protection mechanisms 
may be impeded in the cell. During synthesis of proteins, the nascent chains may have 
not yet formed the necessary interactions to protect aggregation-prone sequences. 
Moreover, in addition to the natural motions of native proteins that expose aggregation 
hotspots the extremely crowded cellular environment makes it highly desirable to form 
aggregates. Thus, evolution has accounted several ways to prevent these dreadful 
outcomes. The most obvious cellular strategy is the existence of robust quality control 
machineries that either assist proper folding or eliminate aberrant proteins. The complex 
network of molecular chaperones consists of facilitators in de novo folding, refolding of 
stress-denatured proteins, disaggregation, oligomeric assembly, protein trafficking and 
assistance in proteolytic degradation (Hartl, et al., 2011). Interplay between molecular 
chaperones and proteases are crucial in maintaining a functional proteome (Powers, et 
al., 2012). However, since protein production can overwhelm the proteostasis network, 
protein expression is also regulated. There is a very strong anti-correlation between in 
vivo expression levels and rates of aggregation in proteins (Tartaglia, et al., 2007). In 
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addition, since aggregation is concentration dependent, abundant proteins were found to 
be highly soluble in cells (Castillo, et al., 2011). However, these proteins although highly 
soluble can become susceptible to aggregation at high concentrations therefore these 
are tightly regulated at the gene-expression level (Castillo, et al., 2011). Another 
protective mechanism is cellular organization. It is tempting to think that the cellular 
environment is a random mesh of non-specific interactions. In reality the cellular 
environment is highly organized and designed for specific protein-protein interactions 
(Pastore & Temussi, 2012). Furthermore, cellular machineries are spatially organized 
and compartmentalization allows efficient folding in vivo (Gershenson & Gierasch, 2011). 
In addition to this, proteins in cells are designed to self-organize into large multiprotein 
complexes to prevent exposure of sticky surfaces (Gierasch & Gershenson, 2009). 
There is also a high correlation between aggregation propensity and turnover rate of 
proteins (De Baets, et al., 2011). Short-living proteins have been found to be more 
aggregation-prone and have less chaperone interactions than proteins that live longer 
(De Baets, et al., 2011).  
 
3.1.4. Functional Dynamics of CRABP 1  
The functional dynamics and interactions with the ligand of members of ILBP 
family including CRABP 1, our model protein is well characterized. Here, I will review 
what is known about the shared dynamic behavior of this family and CRABP 1 to clearly 
demonstrate further on their structural susceptibility of towards aggregation.  
 
3.1.4.1. Function of CRABP 1 
The intracellular lipid binding protein family is involved in sequestering and 
transport of fatty acids in the cytoplasm. These proteins have been shown to be 
important cellular processes such as signal transduction, gene expression, growth and 
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differentiation (Zimmerman & Veerkamp, 2002). Cellular retinoic acid binding proteins in 
particular have two isoforms, CRABP 1 and CRABP 2. CRABPs bind to all-trans retinoic 
acids, to regulate gene transcription, cell proliferation and cell di!erentiation. CRABP 1 
and CRABP 2 are highly homologous with 74% sequence identity and are extremely 
conserved among species (Noy, 2000, Marcelino, et al., 2006). Despite the high 
similarity CRABPs have different patterns of expression across cell types and at various 
stages of development suggesting functional diversity (Noy, 2000). Both isoforms are 
found in the cytoplasm while CRABP 2 is also localized in the nucleus. CRABP 1 and 
CRABP 2 similarly bind retinoic acid but have distinct modes of transport (Noy, 2000, 
Stachurska, et al., 2011). CRABP 1 is ubiquitous and is involved in enhancing retinoic 
acid catabolism and buffering retinoic acid concentrations in cells (Stachurska, et al., 
2011). CRABP 1 modulates catalysis of retinoic acid metabolism by associating with 
cytochromes P450 and discriminates trans-retinoic acid from cis-retinoic acid (Fiorella & 
Napoli, 1991, Noy, 2000). However the exact mechanism of how CRABP 1 regulates 
retinoic acid in cells still remains unclear. On the other hand, CRABP 2 activates nuclear 
retinoic acid receptors (RAR) and regulates retinoic-acid-dependent genes (Stachurska, 
et al., 2011). The affinity of CRABP 1 (Kd<0.4nM) for retinoic acid is higher compared to 
CRABP 2 (Kd=2nM) (Norris, et al., 1994). 
 
3.1.4.2. Dynamic Properties of CRABP 1 and Implications for Ligand Binding 
Attributing to similar functions to transport large hydrophobic ligands ILBPs have 
strong structural homology across species, cell types and ligands for this protein family 
(Marcelino, Smock et al. 2006). The overall structure of ILBPs consists of an internal 
cavity filled with ordered water molecules and a helix-turn-helix cap. A small opening 
enclosed between the helical domain and turns 2 and 4 acts as a portal region of the 
protein. Based on several crystallographic studies on ILBPs, ligands are bound within 
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the barrel in a central internal water-filled cavity (Jamison, et al., 1994, Donovan, et al., 
1995, Jamison, et al., 1998, Zhu, et al., 1999, Krishnan, et al., 2000). The side chains of 
buried hydrophobic amino acids govern the specificity and volume of the internal cavity 
(Noy, 2000). In addition, water molecules in the cavity contribute to the protein’s stability 
and proposed to assist in the displacement of ligands. The volume of cavities varies for 
members of the family and correlates with the size of its ligand. Common ligand-binding 
residues located at the helical motif, strands 2, 3, 4, 8, 9, 10 and turn 2 have been 
identified in most ILBPs (Marcelino, et al., 2006). However the nature of the cavity in this 
family is not well conserved. It is proposed that ILBPs require favorable hydrophobic 
interactions to encapsulate the ligand but maintain large solvent-filled cavities to 
accommodate diverse lipids (Massolini & Calleri, 2003, Marcelino, et al., 2006).  
 
In particular the crystal structure of holo-CRABP 1 shows retinoic acid buried in 
the binding cavity where the carboxy group interacts with two arginine residues and one 
tyrosine residue at the end pocket. The β-ionone ring is twisted into a cis-like 
configuration relative to the isoprene tail, and fits snugly at the portal region leaving only 
one end accessible to the solvent (Kleywegt, et al., 1994, Thompson, et al., 1995). Thus 
in this closed ligand-bound conformation access to the entrance of the ligand-binding 
pocket of CRABP 1 is restricted, implying that significant structural changes are required 
to release the ligand. 
 
It is currently recognized that the conformational flexibility of CRABP 1 like other 
members of the iLBP family is associated with its function to recognize and bind ligand. 
The highly flexible and conserved helical subdomain identifies the correct ligand to bind. 
It is proposed that electrostatic interactions at the edge of the portal attract ligand into 
the interior of the cavity (Zimmerman & Veerkamp, 2002). A conserved gap is found 
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between strands 4 and 5 with no inter-strand hydrogen bonds is instead occupied by 
ordered water molecules.  
 
There have been three proposed mechanisms of ligand entry in iLBPs. One 
mechanism based on well-ordered and superimposable crystal structures of apo and 
holo forms of rat intestinal fatty acid binding protein, states that entry of the ligand 
through the small portal requires minimal changes in the backbone conformation 
(Sacchettini, et al., 1992, Sacchettini & Gordon, 1993). It is hypothesized that entry of 
the ligand into the portal pushes the water molecules through the conserved gap similar 
to a “water pump” (Sacchettini, et al., 1992). However this was challenged by another 
hypothesis where ligand binding was shown to promote significant backbone 
conformational changes. Limited proteolysis on cellular retinol binding proteins (CRBP I 
and CRBP II), CRABP 1 and heart FABP revealed differential proteolytic patterns 
between the apo and holo forms of the proteins (Jamison, et al., 1994). Increased 
susceptibility for digestion at the entry site of the apo form compared to the holo-form 
suggests an open conformation in the absence of a ligand. This was also supported by 
prominent differences in crystal structures of apo and holo forms of CRABP 1, showing a 
ligand accessible form where turn II moves away from the β-barrel (Thompson, et al., 
1995). Upon ligand binding the protein is locked in a closed state (Thompson, et al., 
1995). In an NMR study the apo-form of CRABP 1 shows a more flexible C-terminus of 
helix II permitting increased access to the cavity (Rizo, et al., 1994).  
 
However, a refined and detailed mechanism based on NMR studies suggests an 
extended conformational selection process by which ligand binds. Hodsdon and Cistola 
in 1997 proposed that existing locally disordered and ordered states of the protein in 
equilibrium in the apo state. Ligand binding consequently stabilizes cooperative 
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interactions shifting the equilibrium towards the ordered conformation. This is also 
referred to as the ‘dynamic portal hypothesis”. Hudsdon and Cistola described four key 
features in the dynamic portal hypothesis. First, there are several locally disordered 
regions in the unbound. These include the C-terminal helix II, the linker between helix II 
and strand 2, turn II and turn IV. These regions are flexible and capable of large 
backbone structural fluctuations opening the portal region. This conformational change is 
a transition between order and disorder where helix II and turn II interactions dissociate 
and the C-terminal helix II is unraveled. Second, binding of ligand shifts the equilibrium 
into an ordered or closed state by stabilizing interactions in the C-termini of helices I and 
II. The C-terminus of helix I is stabilized by a Schellman motif interaction. On the other 
hand the C-terminus of helix II is held by ligand-induced interactions with turn II. Third, 
hydrogen bond interactions between a polar residue in turn II and helix II regulate the 
order-disorder transition, hence the entry and exit of the ligand as well. Lastly, ligands 
are released from the cavity by destabilization of turn II-helix II interactions to shift the 
equilibrium into the disordered state. This may be driven by collision of the holo-protein 
with target intracellular organelles. One proposal regarding the delivery of ligands into 
the membranes requires the portal region (helix II, turns II and IV) to dock into the 
membrane while the other side (strands 2, 3, 6, 7, turn 7 and the N-terminus) is exposed 
to the solvent (Mihajlovic & Lazaridis, 2007).  
 
Conformational exchanges along the portal regions have been consistently 
observed in several ILBPs (Zhu, et al., 1999, Krishnan, et al., 2000, Lu, et al., 2000, Xiao 
& Kaltashov, 2005, Li & Frieden, 2006). In addition, molecular dynamics simulations 
have revealed backbone flexibility in apo-forms of iLBPs (Woolf, et al., 2000, Bakowies & 
Van Gunsteren, 2002, Levin, et al., 2010). Examination of motions and flexibility of 
CRABP 1 showed consistent dynamic behavior at the portal region. Using rapid 
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hydrogen-amide exchange NMR, motions of the apo and holo-forms of CRABP 1 were 
examined (Krishnan, et al., 2000). Significant distinct millisecond timescale motions were 
observed in the portal region of the apo-form of the protein consisting of the C-terminus 
of helix II, helix II-strand 2 linker, turn 2 and turn 4 supporting the dynamic portal 
hypothesis (Krishnan, et al., 2000). In a separate experiment using slow hydrogen 
exchange mass spectrometry, transient structural disorder was observed in the same 
regions of the unbound protein (Xiao & Kaltashov, 2005). When bound to retinoic acid, 
these fast motions are impeded and the flexibility in the portal is significantly reduced 
(Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Retinoic acid also increased the 
conformational stability of strand 10, which contains residues that form two salt bridges 
with the carboxylate group of retinoic acid (Xiao & Kaltashov, 2005). Studies on CRABP 
1, consistent with other ILBPs reveal the crucial role of localized dynamics along the 
portal region in dictating ligand recognition and subsequent conformational stabilization. 
In the next section we will show our results suggesting that despite several protective 
mechanisms against aggregation, this dynamic behavior predisposes the protein to 
aggregation. 
 
3.2. Results 
3.2.1. Aggregation Propensities and Themodynamic Stabilities are Coarsely 
Correlated  
In Chapter 2 we have identified aggregation cores in CRABP 1, which were 
consistent under extremely different conditions and across mutants with different 
propensities to aggregate. Our first instinct was to check whether global unfolding 
exposes these segments of the protein favoring intermolecular contacts. To do this we 
looked for correlation between thermodynamic stabilities and aggregation propensities. 
In order to do this, we checked the solubilities of several CRABP 1 mutants by cell 
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fractionation after overexpression in E. coli with ∆∆GU-N (energetic effect of mutations on 
the free energy of the unfolded state (U) with respect to the native state (N) = ∆GU-N
WT - 
∆GU-N
Mutant) values determined by previous members of the lab. While we have found 
high correlation between aggregation propensities and thermodynamic stabilities based 
on ∆∆GU-N for weakly and highly aggregation-prone variants, the range of stabilities of 
moderately aggregating CRABP 1 variants were relatively broad (Table 1). This coarse 
correlation between stability and aggregation propensities may suggest other 
mechanisms other than global destabilization are involved. The comparable tendencies 
of moderately aggregating mutants to both fold and misfold may suggest that 
aggregation may emerge from a folded intermediate. These mutants are able to acquire 
the native fold based on their high solubility early on during overexpression or during 
expression at low temperatures. The natively folded mutants have been confirmed by 
CD spectroscopy (Appendix H) and intrinsic tryptophan fluorescence spectroscopy 
experiments (Appendix I). 
 
3.2.2. Aggregation of CRABP 1 Proceeds Under Native Conditions  
To test whether a folded intermediate precedes aggregation, we examined 
whether aggregation of CRABP 1 takes place under native conditions. We tested in vitro 
conditions that lead to aggregation of WT* CRABP 1. Addition of low urea 
concentrations or adjusting the pH below 8.0 leads increases aggregation propensity. 
Here we followed aggregation of CRABP 1 at pH 7.0 in the presence of low 
concentrations of urea ranging from 0.5 to 3M (Figure 3.2). We have found an increasing 
trend towards aggregation up to 2.5M urea. Above 3M, aggregation is no longer 
observed. At this range of urea concentrations, CRABP 1 has not yet globally unfolded 
as shown in the equilibrium unfolding of CRABP 1 monitored by intrinsic tryptophan 
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fluorescence (Figure 3.2). At higher urea concentrations (>4M), CRABP 1 begins to 
unfold globally, however we do not observe aggregation under these conditions. To 
observe the effects of low urea concentrations on the aggregation kinetics of CRABP 1, 
we monitored the linear light scattering of CRABP 1 with and without urea. We observe a 
faster rate of aggregation in the protein solution containing 1 M urea (Figure 3.3). Our 
results reveal the existence of a near-native intermediate populated at low urea 
concentrations. In addition, we show that this intermediate cannot be sensitively 
detected using intrinsic tryptophan fluorescence, which has been used to monitor 
unfolding of CRABP 1 (Clark, et al., 1996, Clark, et al., 1998). We also examined the pH 
dependence of CRABP 1 aggregation by monitoring the aggregation propensity of 
CRABP 1 at pH conditions below 8.0. We have found an increasing propensity to 
aggregate as pH is adjusted away from pH 8.0 (Figure 3.4) 
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Figure 3.2. Urea-dependent aggregation and unfolding of CRABP 1.  
 
In red, aggregation of CRABP 1 plotted with urea concentration. Aggregation was 
performed by incubation of 200 uM WT* CRABP 1 in buffer (10 mM phosphate buffer, 5 
mM DTT pH 7.0) with increasing urea concentrations for 12 hours at 37oC. Aggregated 
proteins were quantified by measuring amount of remaining soluble protein after 
aggregation.  
 
In blue, is a representative plot of fraction unfolded protein (blue) as a function of urea 
concentration. Fraction unfolded is measured at different urea concentrations using 
intrinsic tryptophan fluorescence spectroscopy. 
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Figure 3.3. Aggregation kinetics of CRABP 1 with and without urea 
Aggregation of 300 µM WT* CRABP 1 in 10 mM phosphate buffer, 5 mM DTT pH 7.0 
monitored by linear light scattering without (filled circles) and with (open circles) 1.5M 
urea. 
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Figure 3.4. pH-dependence of CRABP 1 aggregation.  
Aggregation reactions were performed on 200 µM WT* CRABP 1 at 37oC at different pH 
conditions.  
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3.2.3. Near-Native Dynamic Intermediate of CRABP 1 Leads to Aggregation  
To provide detailed structural information regarding the species responsible for 
the low urea dependent aggregation, we conducted equilibrium unfolding experiments 
and monitored chemical shift perturbations by NMR. By monitoring changes in chemical 
shifts of amino acid residues upon urea titration, we are able to identify regions of the 
proteins that are perturbed by urea. Consistent with our model we observed the 
population of a native-like intermediate prior to unfolding of CRABP 1. We describe our 
findings on the urea unfolding of CRABP 1 as a two-step process. The first step takes 
place at low urea concentrations manifesting a two-state transition, which is fast in the 
NMR timescale (us-ms timescale) (Figure 3.5). A quick glance at the overall spectra 
shows that only a few peaks are affected by urea. Most of the residual peaks at low urea 
concentrations did not deviate from the chemical shifts corresponding to the native 
protein (0M urea). We have looked closely at the few peaks perturbed by low urea and 
found a two state equilibrium exists under these conditions (Figure 3.6). This suggests a 
dynamic interconversion between states. This suggests that the intermediate being 
populated as urea concentration is increased resembles that of the native state. The 
interchange between the two species is fast as evidenced by single broadened peaks. 
Broadening of peaks means that the rate of exchange between is faster compared to the 
chemical shift differences of the two resonance lines. This suggests a dynamic 
interconversion exists between the two structurally similar species. We will refer to this 
intermediate as the N* state. The second step involves global unfolding depicted by the 
slow transition from the N* state into the unfolded protein (Figure 3.7). In the second 
step, as shown in concentrations above 3.5M, two species are in equilibrium, the N* 
state and the unfolded state (U). This can be observed in the HSQC spectrum of CRABP 
1 in 4M urea where peaks corresponding to both the N* state and U states are visible 
(Figures 3.7 and 3.8). At this urea concentration, the interconversion is said to be slow 
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because the rates of exchange is smaller compared to the chemical shift differences 
allowing the two resonance lines to be resolved.  
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Figure 3.5. Overlay of 1H-15N HSQC spectra of CRABP 1 at different urea 
concentrations showing the first (fast) step of urea equilibrium unfolding of 
CRABP 1 (N!N*). Colors represent increasing urea concentrations from 0.5 M (yellow) 
to 3.5 M (red). Unperturbed chemical shifts in the absence of urea, in black.  
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Figure 3.6. 1H and 15N chemical shifts monitored as a function of urea 
concentration for highly perturbed residues. CRABP 1 undergoes a transition from 
N-state ! N*-state. at low urea concentrations  
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Figure 3.7. Overlay of 1H-15N HSQC spectra of CRABP 1 at different urea 
concentrations showing the second (slow) step of urea equilibrium unfolding of 
CRABP 1 (N*!U). Colors represent urea concentrations 4M (blue) and 8M (red). 
Unperturbed chemical shifts in the absence of urea, in black. In 4M urea, CRABP 1 
exists in equilibrium as N, N* and U states. 
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Figure 3.8. Selected regions of the overlapped 1H-15N HSQC spectra of CRABP 1 at 
different urea concentrations showing the second (slow) step of urea equilibrium 
unfolding of CRABP 1 (N*!U). Colors represent urea concentrations 4M (blue) and 
8M (red). Unperturbed chemical shifts in the absence of urea, in black. Shown is residue 
T75 where peaks appear in both the N* and U in states in 4M urea.  
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To gain insight on this intermediate, we identified residues perturbed by urea and 
projected them on to the structure of CRABP 1 (Figure 3.9). These residues include the 
helical subdomain and several loop regions of the protein. Inspection of the highly 
perturbed regions supports a dynamic movement of the helical region away from the β-
barrel structure. Furthermore, the intermediate is characterized by moderate 
perturbations in the beta strands suggesting an increased breathing in the beta barrel 
subdomain with large motions along the loop regions.  
 
We further examined this intermediate using native state hydrogen deuterium 
exchange NMR. We performed hydrogen exchange on WT* CRABP 1 with and without 
urea. Our experiments showed fast amide backbone proton exchange along the helical 
subdomain, loops and turns of the protein (Figure 3.10). Addition of urea increased the 
rates of exchange in the same regions of the protein (Figure 3.11A). Figure 3.11B shows 
that urea only increased the rate of exchange as seen with the faster decrease in 
intensity with urea for representative residues. Our observations on our hydrogen 
exchange experiments cannot completely dissociate the possibility of unfolding. 
However, we found very good correlation between the perturbed residues from our 
chemical shift perturbation analysis and highly solvent accessible residues identified by 
hydrogen exchange (Figure 3.12). In addition residues that have been identified using 
both methods corresponded to dynamic regions in the portal of the protein reported 
previously by fast hydrogen exchange NMR and slow hydrogen exchange MS 
experiments on CRABP 1 (Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Previous 
rapid water-amide hydrogen exchange and our chemical shift perturbation analysis 
showed consistent dynamic regions in apo-CRABP 1 (Appendix J). In addition to this, we 
performed partial trypsin digestion of CRABP 1. We observed faster digestion of trypsin 
with upon addition of urea (Appendix K and Appendix L). The two major masses that 
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were generated from the mass spectra of all the tryptic peptide fragments have values of 
11079.2 and 7127.5 (average masses). The analyses yielded other peptide masses that 
are within the range of 10000-12000 for the larger fragments and 6000-8000 for the 
smaller ones. The predominant fragment (MW=6393) corresponded to residues along 
turn 4 (regions around R78, K79 and R81), which is part of the ligand portal. Increased 
protease accessibility was also previously reported corresponding to increased 
dynamics of the apo CRABP 1 (Jamison, et al., 1994). We are currently working on 
experiments to identify other regions of the CRABP 1 that become more accessible to 
proteases in the N* state. Our data suggests that enhancement of the movement of the 
helical subdomain and increased breathing of the beta barrel region of CRABP 1 which 
is an intrinsic behavior of the protein to accommodate its ligand also relaxes stable 
interactions between the beta stands leading to exposure of the aggregation-prone 
sequences. 
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Figure 3.9. Residues perturbed by urea mapped on to the structure of CRABP 1. 
Residues in CRABP 1 that showed high (green spheres) and moderate (green highlight) 
chemical shift perturbation upon addition of low amounts of urea.  
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Figure 3.10. Backbone solvent accessibility of WT* CRABP 1. Fast exchanging 
(yellow) and slow exchanging residues (blue) monitored by H/D exchange were 
consistent in with and without urea. Residues not analyzed are in black. 
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Figure 3.11. Exchange rates of CRABP 1 residues with and without urea 
 
A) Rates of backbone amide proton exchange of amino acid residues of WT* CRABP 1 
with (red dotted lines) and without (blue dotted lines) of urea. β-strands (highlighted in 
yellow) and α helices (highlighted in teal) in the sequence are shown. Aggregation core 
sequences are highlighted in black. 
 
B) Ratio of peak intensities with time of representative residues in WT* CRABP 1 with 
(red) and without (blue) urea. I0: peak intensity before exchange; Iex: peak intensity after 
exchange.  
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Figure 3.12. Highly dynamic near native intermediate exposes aggregation-prone 
sequences. 
 
Regions of CRABP 1 with high chemical shift perturbation and fast exchanging residues 
monitored by HX-NMR (purple spheres), high chemical shift perturbation only (blue 
spheres), fast exchanging residues only monitored H/D exchange NMR (red spheres) 
and aggregation cores (orange highlight) mapped on to the CRABP 1 structure. 
Residues sensitive to urea cluster along regions of the protein that allows exposure of 
aggregation cores.  
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3.2.4. Effect of single residue substitutions on CRABP 1 aggregation 
To examine the effects of mutations that leads to aggregation, we monitored 
chemical shift perturbations brought about by single residue substitutions around the 
aggregation cores F50M, F65M, G68A, F71M, G78A (core residues 51-65) and L118V 
(C-terminal core) (Figure 3.13). We have only observed local perturbations near the 
mutation sites in these variants suggesting that global unfolding of the protein is not 
required in these mutants. Our data suggests that local perturbations around the core 
sequences in the folded structure may be increasing the dynamics of the protein and 
enhances the exposure of these aggregation-prone segments. We are currently 
validating our observations by monitoring the dynamics of aggregation-prone mutants 
using hydrogen exchange. 
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Figure 3.13. Locations of single residue substitutions that favor aggregation 
mapped with aggregation cores. Aggregation-prone mutants CRABP 1 only lead to 
local perturbations in the structure. Amino acid residues that have been mutated and 
shown increased propensities to aggregate (teal spheres) are clustered close to the 
aggregation cores. Chemical shift analysis of these mutant proteins showed only local 
perturbations near the mutation sites.  
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3.2.5. Retinoic acid binding decreases aggregation of WT* CRABP 1 
It has been previously reported that binding of retinoic acid reduces the dynamics 
of CRABP 1 (Krishnan, et al., 2000, Xiao & Kaltashov, 2005). To test whether 
stabilization of CRABP 1 by retinoic acid can decrease the aggregation of CRABP 1 we 
performed an in vitro aggregation assay and monitored formation of aggregates with and 
without retinoic acid. Since aggregation is a stochastic process, we performed multiple 
trials to test the effect of retinoic acid on the aggregation propensity of CRABP 1. We 
performed our assay under conditions that favor aggregation of CRABP 1 - high 
concentrations (200 uM and above) in the presence of 1.5 M urea at pH 7.0 (Figure 
3.14A). We found that the propensity to aggregate was greatly reduced by retinoic acid 
(Figure 3.14). Out of 69 independent aggregation reactions, only 15 reactions showed at 
least 20% of monomers forming aggregates in the presence of retinoic acid (Figure 
3.14B) in contrast to 54 out of 77 independent aggregation reactions with at least 20% 
monomers forming aggregates without retinoic acid (Figure 3.14A). Our findings support 
the model that ligand binding prevents CRABP 1 from accessing this open dynamic state 
by locking this helical domain close to the barrel inhibiting exposure of aggregation cores 
preventing aggregation (Figure 3.15). 
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Figure 3.14. Inhibition of CRABP 1 aggregation by retinoic acid. 54 out of 77 
independent aggregation reactions showed at least 20% of CRABP 1 monomers forming 
aggregates (A) while in the presence of retinoic acid, 15 out of 69 independent 
aggregation reactions showed at least 20% of CRABP 1 monomers forming aggregates 
(B). Aggregation reactions were performed by incubating 250-300 µM of soluble CRABP 
1 in phosphate buffer pH 7.0 containing 1.5M urea at 37oC for 2 hours. Amount of 
aggregated proteins were determined by measuring the amount of remaining soluble 
monomers after incubation. 
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Figure 3.15. Conserved sequences in CRABP 1 important for ligand binding and 
aggregation. Conserved ligand binding residues in the iLBP family mapped on to 
CRABP 1 (in red) are critical in not only in ligand interactions but in stabilization of 
aggregation cores in the complex. 
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3.3. Discussion 
Despite several decades of trying to understand protein aggregation, there have 
only been a handful of globular proteins with a well-explored aggregation energy 
landscapes. The idea that native proteins are prone to aggregate has been progressively 
explored recently. However, there is lack of a complete picture describing aggregation 
risks and protective mechanisms from the early steps of folding to the fully functional 
protein. For a long time we have been interested in questions on β-rich proteins: What 
signals in the protein sequence favor folding over aggregation of these highly 
aggregation-prone motifs? How do these proteins perform their functions despite the risk 
of aggregation? We have used knowledge gained over the years on a β-rich protein 
CRABP 1 to address these questions and provide clear connections between folding, 
function and aggregation. In Chapter 2, we demonstrated how a protein’s sequence can 
dictate both folding and aggregation. We have learned that folding assures early 
protection of hydrophobic sequences to avoid aggregation. However, the question 
remains why in spite of this folding driven protection of aggregation-prone segments 
CRABP 1 is susceptible to aggregation under native conditions? We therefore 
hypothesize that similar to other globular proteins, local fluctuations in CRABP 1 may be 
leading to undesirable interactions. In order to provide connections between aggregation 
and motions of the native protein, we identified conditions that favor aggregation and 
examined the species populated. From here, we learned that indeed the protein’s 
dynamic behavior directs exposure of these aggregation-prone segments. 
 
We have found that addition of small amounts of denaturants increases the 
aggregation propensity of CRABP 1. We were able to establish a strong correlation 
between urea concentration and aggregation at concentrations prior to global unfolding 
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of CRABP 1. Over the years, we have used intrinsic tryptophan fluorescence and 
circular dichroism to monitor global unfolding. However, these methods have not been 
sensitive in detecting species that become populated at low urea concentrations. Our 
inability to detect these species using fluorescence methods and CD provided us more 
hints that species leading to aggregation may not be largely destabilized. We therefore 
used NMR and chemical shift perturbation analysis to sensitively monitor populations. In 
addition, HX-NMR and partial proteolysis to monitor solvent and protease accessibility 
were used to support our findings from the chemical shift perturbation analysis. Our data 
from all three methods illustrate a dynamic breathing of CRABP 1 under native 
conditions. Our NMR data on aggregation-prone variants with substitutions around the 
aggregation cores displaying only local perturbations. In addition, we also found that 
aggregation is sensitive to pH. NMR analysis of CRABP 1 in at pH’s from 7 to 8 showed 
perturbation in two histidine residues, His40 and His94. His40 is slightly conserved and 
interacts with Lys8 and Ser 55 (residue in strand 3). Protonation of His40 may break 
interactions with strand 3 (part of aggregation core 1) thus exposing this core to 
aggregation. The pH dependence of CRABP 1 aggregation has to be explored more in 
detail especially at lower pH’s when acidic residues functioning as gatekeepers may be 
perturbed. All together our observations supporting aggregation from mutations that only 
locally perturb CRABP 1 further support an aggregation-prone intermediate with a 
native-like structure.  
 
The conformation we have identified been previously described as a natural 
tendency of the molecule in the absence of retinoic acid. Fluctuations that occur along 
the portal region of CRABP 1 bare the entry site for ligand to access and bind inside the 
cavity. Although this dynamic portal model favoring ligand binding has already been out 
for quite sometime, our data extends brand new insights regarding its role in preceding 
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aggregation. In this dynamic open state, the helical domain dissociates from the β-barrel 
body and breaks interactions with loop II, thus exposing the highly fluctuating 
aggregation-prone strands 3 and 4. In addition, this movement partly unmasks strand 
10, transforming it into an edge strand exposing it to unfavorable intermolecular 
interactions.  
 
In previous reports, it has been emphasized that binding to retinoic halts CRABP 
1 dynamics and stabilizes the protein (Krishnan, Sukumar et al. 2000(Xiao & Kaltashov, 
2005). To support further our claim that similar motions predispose the protein to 
aggregation, we tested whether a stabilized, rigid ligand-bound CRABP 1 is less prone 
to aggregate. Consistent with our hypothesis, we show that retinoic acid is capable of 
inhibiting aggregation. Protective strategies using functional interactions have already 
been observed in proteins as discussed in the previous sections. CRABP 1 aggregation 
presents an excellent case where a hydrophobic ligand protects the same hydrophobic 
regions that drive aggregation. A similar competition between intermolecular interactions 
and ligand binding has also been observed in another lipid binding protein β-
lactoglobulin. This protein has a similar cavity that binds hydrophobic ligands. As 
discussed earlier, binding of ligand dissociates the dimer, which is stabilized by the 
same regions in aggregates (Gutierrez-Magdaleno, Bello et al. 2013; (Hamada, et al., 
2009). The case of acylphosphatase also shows also a similar behavior. NMR 
experiments combined with molecular dynamic simulations show that phosphate ions 
acts as an inhibitor for protein aggregation of acylphosphatase (De Simone, et al., 2011). 
It has been demonstrated that the binding interaction perturbs the energy landscape and 
the dynamics of the protein to prevent aggregation even under conditions where it is 
otherwise favored (De Simone, et al., 2011). This observation is proposed to be a 
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general behavior in protein-ligand interactions to avoid aggregation (De Simone, et al., 
2011). 
 
The functional relevance of the dynamic movement of CRABP 1 is shared with 
other members of the ILBP family. Our findings on the aggregation mechanism of 
CRABP 1 may have similar implications with other ILBPs. This family is not known for 
any aggregation-related diseases. Hence we propose that this may be ascribed to the 
ability of these proteins to shield aggregation via several mechanisms such as rapid 
folding and protective ligand interactions. Ligand specificities of different ILBPs are 
different, however there are conserved binding sites for these proteins. We find several 
conserved binding sites at the helical sub-domain and aggregation-prone segments 
(Figure 3.16). Our results imply that the interaction between the ligand with the helical 
lid, loop 2, strands 3, 4, 9 and 10 have multiple functions: 1) to functionally lock the 
ligand into the cavity with the helical lid; 2) to halt the motions along the portal region to 
stabilize the complex; 3) to stabilize fluctuations in loop 2, strands 3 and 4 to prevent 
exposure to aggregation; 4) to stabilize strand 10 (which forms a salt bridge with the 
ligand) and subsequently strand 9 to avoid aggregation. Ironically, in all our folding 
studies we have used the stabilized variant of CRABP 1, R131Q. As can be recalled, 
Arg131 (which is part of the C-terminal aggregation-prone strand) forms a salt bridge 
with the carboxyl group of retinoic acid to stabilize the complex. Mutation of Arg131 into 
glutamine destabilizes the complex however increases the solubility and stability of 
CRABP 1. This further suggests Arg131 interaction with retinoic acid offsets the lowered 
solubility and stability of CRABP 1. 
 
Hence we propose a model where under native conditions CRABP 1 is an 
ensemble of low-energy states with slightly different energies separated by defined 
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barriers. One of these states is a relatively higher energy open conformation, N* state 
capable of both ligand binding and intermolecular association. In the presence of a 
ligand, the equilibrium is shifted towards the lowest energy ligand-bound state. However, 
in the absence of the ligand at high CRABP 1 concentrations, this high-energy state 
becomes sufficiently populated permitting intermolecular associations shifting the 
equilibrium towards the very low energy aggregated state (Figure 3.16).  
 
In the absence of the ligand, how is the native protein protected from 
aggregation? Analysis of the CRABP 1 sequence reveals presence of aggregation 
gatekeepers (Clouser, 2011). These include D16, E17, K20, K30, D125 and D126. It is 
predicted that helix II and partly helix I is highly aggregation-prone however we have not 
found these in the aggregation cores. Thus, the presence of these charged residues 
(D16, E17, K20 and K30) possibly safeguards this region against aggregation. We also 
observed that residues D125 and D126 disrupt the aggregation core in the C-terminal 
end of the protein resulting in a small gap between the aggregation cores. Thus, these 
charged residues identified function as aggregation gatekeepers of CRABP 1. In addition 
cellular conditions also protect CRABP 1 aggregation.  
 
As we have discussed previously, aside from the general housekeeping 
machineries that prevent aggregation in cells, protein concentrations of aggregation-
prone species are largely regulated. In human cells, CRABP 1 concentration is very low 
(1-10 µM) and has relatively low saturation for retinoic acid (40nm) around 5% saturated 
(Donovan, et al., 1995). Despite not having enough ligand in to bind retinoic acid, the 
concentration of CRABP 1 is regulated to prevent aggregation. The cellular maintenance 
of low CRABP 1 concentrations may be a mechanistic control to limit the amount of N* 
state enough to trigger aggregation.  
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Figure 3.16. Proposed aggregation free energy landscape of CRABP 1 under 
native conditions. Native CRABP 1 samples a near-native conformation (N*), which is 
linked to both ligand binding and aggregation. N* state can bind to retinoic acid to form a 
stable complex or self-associate to form highly stable amorphous aggregates. This 
illustrates the role of retinoic acid interaction in restructuring the energy landscape of 
CRABP 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
124 
 
  125 
 
In summary our work not only provides another case of a globular protein 
aggregating from the native state but also describes natural features of the protein that 
present risks to aggregation. As described earlier in this chapter, there have been only a 
very few cases reported wherein oligomerization and binding interfaces also predispose 
proteins to aggregation. The case of CRABP 1 presents a clear illustration of functional 
interactions as protective mechanisms against aggregation. The overlap between 
functional ligand binding interfaces and aggregation-prone regions highlights the 
importance of natural ligands in designing small molecules against aggregation. In 
addition, our contribution to the growing number of cases where globular proteins 
aggregate from the native state supports the idea that not only folding dictates 
aggregation propensity but the inherent motions of proteins as well. Although this implies 
specific approaches in studying aggregation of globular proteins, shared characteristics 
within protein families can also provide hints on their behaviors. Lastly, we have shown 
that evolutionarily fine-tuned folding of a protein does not guarantee protection from 
aggregation therefore this emphasizes the critical role cellular housekeeping 
machineries to regulate protein concentrations in their soluble and functional states. 
 
3.4. Experimental Procedures 
In Vitro Aggregation Assays 
WT* CRABP 1 proteins were generated using the same protocol described in 
Chapter 2. Protein solution aliquots with known concentrations were lyophilized. 
Lyophilized proteins were resuspended in buffer (10 mM phosphate buffer, 5 mM DTT 
pH 7.0) containing different urea concentrations (0 to 3.0M) to a total reaction volume of 
100uL. Each tube contains 200 µM of pure CRABP 1 protein. Aggregation reactions 
were incubated and agitated at 1000rpm using a thermo shaker at 37oC for 12 hours. 
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The amounts of soluble protein before and after aggregation were measured from
absorbance at 280nm (A280) of protein diluted in 8M urea. The same protocol was also 
used to determine aggregates formed at different pH conditions. Briefly, aggregation of 
CRABP 1 was monitored using phosphate buffers with pH’s from 6.0 to 8.0. Percent of 
aggregated protein was determined by taking the ratio of the difference in A280 before 
and after aggregation with respect to the initial concentration. A280(t=0) and A280(t=12) 
are absorbance readings at 280nm before and after aggregation.  
 
To monitor the effect of retinoic acid on WT* CRABP 1 aggregation, we 
compared the amounts of aggregates formed after two hours of aggregation at 37oC 
using the same method described above in the presence and absence of 100 µM
retinoic acid.  
The effect of urea on the rate of aggregation was determined by measuring the light 
scattering at 350nm every 30 seconds of 300 µM WT* CRABP 1 in buffer (10 mM
phosphate buffer pH 7.0 containing 5 mM DTT) with and without 1.5M urea using Varian 
Cary 50 UV-Vis Spectrophotometer. 
Equilibrium Unfolding Experiments 
Equilibrium unfolding of WT* CRABP 1 in the presence of 0 to 8M urea were 
monitored using solution NMR spectroscopy. 15N-labeled WT* CRABP 1 was dissolved 
in buffer (20 mM Tris buffer, 5 mM DTT, 5% (v/v) D2O pH=8.0) with or without urea. 
HSQC spectra of WT* CRABP 1 for each urea concentration were recorded at 26 °C on 
a 600-MHz Bruker Avance spectrometer using a TXI cryoprobe. Data were processed 
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using NMRPipe (Delaglio, et al., 1995) and analyzed using Cara software (Keller, 2004). 
15N and proton chemical shifts for amino acid residues were assigned de novo using 
triple resonance experiments HNCO, HNCACB, HNcoCACB. 
 
Proteolysis of WT* CRABP 1  
To determine the solvent accessibility of WT* CRABP 1 urea, we performed 
limited trypsin digestion on WT* CRABP 1 with and without urea. WT* CRABP 1 was 
dissolved in proteolysis buffer (10 mM Tris-HCl pH 7.6, 50 mM NaCl, 2mM CaCl2) and 
treated with Trypsin Gold (Promega) to a trypsin:protein (w/w) concentration of 1:25 at 
different time points at 30oC. Tryptic digests were ran in 15% Tricine SDS-PAGE for 
analysis. MS experiments were done on a QStar XL Quadrupole TOF Mass 
Spectrometer using TurboIon electrospray ionization. LC-MS/MS was done after 
separation of the tryptic peptides on a C18 RP column using a gradient elution of 0-95% 
acetonitrile/0.1% formic acid at a flow rate of 200 µL/min over 30 mins. MS peaks were 
further fragmented for sequencing by collision-induced dissociation (CID). The mass 
spectra were analyzed using the Bayesian Protein Reconstruct tool in AnalystQS 
software while peptide sequences were determined by de novo sequencing. 
 
Hydrogen Exchange of NMR 
Hydrogen exchange was performed on WT* CRABP 1 in the presence and 
absence of 1.5M urea. Lyophilized 15N-labeled WT* CRABP 1 was dissolved in buffer 
(20 mM Tris-d11, 5 mM DTT pH 8.0) with or without 1.5M urea and lyophilized overnight. 
Lyophilized protein was re-dissolved in D2O. H/D exchange was followed by 
measurement of peak intensities in HSQC spectra acquired at different time times after 
transfer of the protein in D2O. 
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HSQCs were recorded at 26oC using a 700 MHz Varian NMR system equipped 
with a cryogenically cooled triple-resonance probe. Total acquisition time for each 2D 
HSQC spectrum was about 15 min. Data were processed using NMRPipe (Delaglio, et 
al., 1995). Peak intensities for assigned residues as a function of time were analyzed 
Peak intensities for assigned residues as a function of time were analyzed using 
homemade Mathematica scripts.  
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CHAPTER 4 
CONCLUSIONS 
 
4.1. Summary 
A polypeptide’s amino acid sequence has evolved to contain all necessary 
information for proper folding and function. However, these interactions likewise govern 
aggregation, which is associated in a number of catastrophic diseases. Thus, inherent 
risks are also encoded in the protein sequence. In this thesis, we investigated the 
existence of sequence determinants for folding and misfolding. To explore the molecular 
basis of protein aggregation and to find connections with folding, we employed CRABP 
1, a model β-rich protein with a complex topology and rugged energy landscape. Taking 
advantage of several aggregation-prone mutants of CRABP 1, we have identified 
aggregation-driving sequences in in vitro and in vivo aggregates. These short contiguous 
amino acid segments encompass the ligand-binding portal and strands at the C-terminal 
end of the protein consisting the aggregation interfaces. These aggregation cores 
constitute aggregates derived in vitro and in vivo. Moreover, the experimentally 
determined aggregation cores validated several sequence-based aggregation 
predictions. However, we find that sequence-based predictions cannot fully recapitulate 
the overall aggregation propensities of single residue mutants. Hence, considerations for 
additional parameters are necessary to predict aggregation propensities such as protein 
thermodynamic stabilities and dynamics. Our analysis of the aggregation core 
sequences of CRABP 1 revealed clear connections between one of the cores, the C-
terminal strand and folding. Folding studies indicate the critical role of N and C-terminal 
docking during the early stages of barrel closure. Thus, we have learned that 
fundamental steps in folding are directed by the protein’s natural tendency to avoid 
aggregation. 
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Our awareness on the role of folding as a protective mechanism from 
aggregation led us to more questions on how proteins evade this. We further examined 
the behavior of CRABP 1 under native conditions and resolved intermediates that 
precede aggregation. Under non-denaturing conditions, we found that the natural 
motions of CRABP 1 associated with its role to bind ligand triggers aggregation. The 
dynamic behavior of CRABP 1 to open its ligand-binding portal to permit ligand access 
exposes the aggregation cores. We further found the role of the ligand, retinoic acid in 
stabilizing the complex, essential in preventing aggregation. We also established 
connections with members of intracellular binding proteins that contain conserved 
binding residues for ligands as these are located along the aggregation cores, further 
justifying the importance of ligand interaction as a protection from aggregation. Finally, 
we emphasized the relevance of low expression levels in vivo of CRABP 1 in facilitating 
folding and function over aggregation.  
 
4.2. Implications for Future Studies 
This thesis has provided a holistic examination on three important intrinsic 
behaviors of proteins: folding, functional dynamics and aggregation. It has provided the 
much-needed linkage between the evolutionary requirement for proper folding for 
function, as well as the inability to completely eliminate the risk of aggregation. The 
foundations contributed on understanding the energy landscape of CRABP 1 opens 
opportunities to explore other areas of the landscape including aggregation under non-
native conditions. In addition, our knowledge of aggregation-prone sequences in the 
protein will assist further studies on conserved residues (aggregation gatekeepers) that 
restrict aggregation. A more detailed analysis of the aggregation kinetics of CRABP 1 
and its mutants may also provide additional insights in guiding predictions for 
aggregation propensities. Likewise, CRABP 1 and its mutants may be used for 
  131 
interrogating the roles of cellular quality control machineries (chaperones, degradation). 
Currently, there is still a modest amount of information showing direct links between 
protein sequence and interactions with the different quality control machineries. Interplay 
and competition for hydrophobic sequences in folding, aggregation, function and that of 
chaperones and degradation enzymes still remains to be understood in detail. CRABP 1 
may be an excellent model for these studies to extract generic concepts in explaining 
protein folding in the cell.  
 
From an evolutionary point of view, it remains intriguing how proteins have not 
been efficiently selected against sequences that trigger aggregation. It is 
comprehensible that aggregation-prone sequences and dynamic motions of proteins are 
critical for function thus cannot be completely selected against, giving rise to intrinsic and 
cellular protection mechanisms against aggregation. However, it remains confounding 
why despite redundant protective mechanisms, there are still a growing number of 
misfolding diseases. Hence, it brings also to the table the evolutionary constraint for 
proteins to be multifunctional in the form of intrinsically disordered proteins. The 
existence of disorder in proteins permits multiple functions but also consequently lead to 
aggregation-related disease states. Therefore, understanding the balance between 
evolutionary selection for optimal protein function and threat for misfolding and 
aggregation remains as a huge area of study. 
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APPENDIX A 
PREDICTED AGGREGATION PROPENSITY OF CRABP 1 
Aggregation propensities were predicted using Zyggregator (a), AGGRESCAN (b) and 
TANGO (c). 
A 
 
B 
 
C 
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APPENDIX B 
LOCATION OF MUTATIONS AFFECTING THE PREDICTED AGGREGATION 
PROPENSITY OF CRABP 1
Isoleucine 52 is located in strand 2 (green sphere) and leucine 118 (blue sphere) is in 
strand 9 of CRABP 1. 
 
 
134 
APPENDIX C 
PREDICTED AGGREGATION PROPENSITIES OF WT* AND I52A CRABP 1 
Decreased aggregation propensities were observed around the mutation site predicted 
by Zyggregator. 
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APPENDIX D 
 PREDICTED AGGREGATION PROPENSITIES OF WT* AND L118V CRABP 1 
Increased aggregation propensities were observed around the mutation site predicted by 
Zyggregator. 
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APPENDIX E 
TRANSMISSION ELECTRON MICROSCOPY IMAGES OF CRABP 1 AGGREGATES  
F71A in vitro and in vivo aggregates were resuspended in water. Ten microliters of the 
aggregate resuspension was dropped on to carbon-coated copper discs. Concentrations 
of samples were optimized so that only a very thin layer of aggregates forms at the 
surface of the disc. Samples were dried out for a few minutes. Ten microliters of 1% 
phosphotungstic acid was dropped on to the disc and allowed to dry for a few minutes. 
After this, excess stain was washed off with distilled water. Discs were dries overnight 
prior to visualization. In vivo aggregates (A) appeared as uniform globular structures in 
contrast to the very amorphous in vitro aggregates (B).  
A) 
 
B) 
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APPENDIX F 
SDS-PAGE OF PURIFIED INCLUSION BODIES FROM SEVERAL AGGREGATION-
PRONE MUTANTS
Several aggregation-prone mutants were purified using a mild non-ionic detergent. 
Mutant CRABP 1 proteins predominantly consist the purified inclusion bodies. 
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APPENDIX G 
WESTERN BLOT OF CRABP 1 INCLUSION BODIES TO DETECT SMALL HEAT 
SHOCK PROTEIN IBPA.
Inclusion bodies were probed against IbpA using rabbit anti-IbpA serum (from Dr. Tania 
Baker, MIT) and anti- rabbit IgG AP conjugate as secondary antibody. Blots were 
developed using Lumiphos reagent (Thermo Scientific).  
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APPENDIX H 
CD SPECTRA OF WT* AND L118V MUTANT CRABP 1 
WT* (triangles) and L118V (squares) mutant CRABP I proteins (10 µM protein in 10 mM 
Tris-HCl, 1mM TCEP pH 8.0) show similar CD spectra. CD signals were converted to 
molar ellipticity (θ). CD spectra collected was an average of 10 scans. Mutant CRABP 1 
contains the CD inflection at 228nm, which is characteristic of tertiary packing involving 
aromatic clustering around Trp 87 and the aromatic-charge interaction between Arg 111 
and Trp 109 in the native protein (Clark, et al., 1996) 
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APPENDIX I 
FLUORESCENCE SPECTRA OF WT* AND L118V MUTANT CRABP 1 
Intrinsic tryptophan fluorescence spectroscopy was performed on 4uM WT* and L118V 
mutant proteins in 10 mM Tris-HCl pH 8.0, 1mM DTT. Spectrum of L118V CRABP 1 
(squares) was very similar to that of the WT* CRABP 1 spectrum (triangles). Maximum 
fluorescence is observed at 330nm is observed in the native protein and is quenched 
relative to the denatured state. Fluorescence quenching is attributed to the proximity of 
Trp 109 to Cys95 in the native state (Clark, et al., 1996). 
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APPENDIX J 
DYNAMIC REGIONS OF APO-CRABP 1 FROM FAST HYDROGEN EXCHANGE 
EXPERIMENTS
 
Shown in thick tubes are residues of CRABP 1 undergoing fast fluctuations in the 
absence of CRABP 1. This figure is re-printed from (Krishnan, et al., 2000) 
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APPENDIX K 
PARTIAL PROTEOLYSIS OF CRABP 1 
Partial trypsin digestion of CRABP 1 in 10 mM Tris-HCl pH 7.6, 50 mM NaCl, 2mM 
CaCl2 showed appearance of two major fragments. Positions of fragments 1 (12KDa) 
and 2 (6KDa) are indicated. 
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APPENDIX L 
PARTIAL PROTEOLYSIS OF CRABP 1 IN THE PRESENCE OF UREA 
Partial trypsin digestion of CRABP 1 in 10 mM Tris-HCl pH 7.6, 50 mM NaCl, 2mM 
CaCl2 ,1M urea showed appearance of two major fragments. The rate of proteolysis is 
faster with 1M urea than without (Appendix K). Positions of fragments 1 (12KDa) and 2 
(6KDa) are indicated. 
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